[ { "acronym": null, "application": "Belirsiz", "completionDate": "2028-08-31", "conditions": "Breast Cancer, Breast Carcinoma, Malignant Neoplasm of Breast", "enrollment": "27", "interventions": "", "nct": "NCT02204098", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Washington University School of Medicine", "startDate": "2015-01-07", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy", "url": "https://clinicaltrials.gov/study/NCT02204098" }, { "acronym": null, "application": "IRE", "completionDate": "2030-01", "conditions": "Pancreatic Cancer", "enrollment": "500", "interventions": "", "nct": "NCT02674100", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": "IRE", "resultsReported": "hayir", "sponsor": "University of Louisville", "startDate": "2016-01", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry", "url": "https://clinicaltrials.gov/study/NCT02674100" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2027-03-09", "conditions": "Chronic Hepatitis, Hepatitis C Infection, Hepatocellular Carcinoma", "enrollment": "33", "interventions": "", "nct": "NCT02772003", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "National Cancer Institute (NCI)", "startDate": "2016-06-06", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection", "url": "https://clinicaltrials.gov/study/NCT02772003" }, { "acronym": null, "application": "IRE", "completionDate": "2029-04-01", "conditions": "Pancreatic Adenocarcinoma", "enrollment": "10", "interventions": "", "nct": "NCT03080974", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "IRE", "resultsReported": "hayir", "sponsor": "University of Louisville", "startDate": "2017-08-14", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma", "url": "https://clinicaltrials.gov/study/NCT03080974" }, { "acronym": null, "application": "ECT", "completionDate": "2023-12-01", "conditions": "Malignant Melanoma", "enrollment": "53", "interventions": "COMBINATION_PRODUCT: Pembrolizumab", "nct": "NCT03448666", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "European Institute of Oncology", "startDate": "2021-03-01", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "INTERVENTIONAL", "summary": "This is a Phase 2 multicenter, open label, non-randomized, interventional study enrolling 53 patients.The objectives and purposes of the clinical study described herein are to determine if concomitant Pembrolizumab (Keytruda) and ECT treatments are safe and able to improve local and systemic response rates.ECT will be performed with the CLINIPORATOR and a single IV dose of Bleomycin", "title": "ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases", "url": "https://clinicaltrials.gov/study/NCT03448666" }, { "acronym": null, "application": "IRE", "completionDate": "2027-07-31", "conditions": "Pancreas Cancer", "enrollment": "20", "interventions": "", "nct": "NCT03484299", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "IRE", "resultsReported": "hayir", "sponsor": "University of Louisville", "startDate": "2018-05-30", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma", "url": "https://clinicaltrials.gov/study/NCT03484299" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2026-12-31", "conditions": "Glioblastoma", "enrollment": "52", "interventions": "", "nct": "NCT03491683", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "hayir", "sponsor": "Inovio Pharmaceuticals", "startDate": "2018-05-31", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)", "url": "https://clinicaltrials.gov/study/NCT03491683" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2039-09-02", "conditions": "Prostate Cancer", "enrollment": "200", "interventions": "", "nct": "NCT03492424", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "Weill Medical College of Cornell University", "startDate": "2018-01-02", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Ablative Therapy in the Management of Prostate Cancer", "url": "https://clinicaltrials.gov/study/NCT03492424" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2028-12", "conditions": "Pancreatic Adenocarcinoma, Liver Metastases", "enrollment": "14", "interventions": "", "nct": "NCT03856658", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Corewell Health West", "startDate": "2019-02-05", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases", "url": "https://clinicaltrials.gov/study/NCT03856658" }, { "acronym": null, "application": "IRE", "completionDate": "2025-04", "conditions": "Stage III Pancreatic Cancer", "enrollment": "528", "interventions": "", "nct": "NCT03899636", "phase": "PHASE3", "phaseLabel": "Faz 3", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Angiodynamics, Inc.", "startDate": "2021-02-23", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT03899636" }, { "acronym": null, "application": "IRE", "completionDate": "2025-04", "conditions": "Stage III Pancreatic Cancer", "enrollment": "532", "interventions": "", "nct": "NCT03899649", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Angiodynamics, Inc.", "startDate": "2019-05-08", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT03899649" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2031-02-28", "conditions": "Pediatric Recurrent Central Nervous System Tumors", "enrollment": "7", "interventions": "", "nct": "NCT03988283", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Washington University School of Medicine", "startDate": "2024-10-02", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors", "url": "https://clinicaltrials.gov/study/NCT03988283" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2029-06", "conditions": "Human Papillomavirus Type 16, Cervical Intraepithelial Neoplasia Grade II, Cervical Intraepithelial Neoplasia, Grade III", "enrollment": "48", "interventions": "", "nct": "NCT04131413", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "startDate": "2020-09-14", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia", "url": "https://clinicaltrials.gov/study/NCT04131413" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2028-11-29", "conditions": "HCC", "enrollment": "36", "interventions": "", "nct": "NCT04251117", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "hayir", "sponsor": "Geneos Therapeutics", "startDate": "2020-03-01", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC", "url": "https://clinicaltrials.gov/study/NCT04251117" }, { "acronym": null, "application": "IRE", "completionDate": "2026-12-31", "conditions": "Locally Advanced Pancreatic Cancer, Irreversible Electroporation", "enrollment": "27", "interventions": "", "nct": "NCT04276857", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "University of Saskatchewan", "startDate": "2025-05-01", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Systemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT04276857" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2027-03", "conditions": "BRCA1/2 Mutation", "enrollment": "44", "interventions": "", "nct": "NCT04367675", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Abramson Cancer Center at Penn Medicine", "startDate": "2021-04-20", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "INO 5401 Vaccination in BRCA1/2 Mutation Carriers", "url": "https://clinicaltrials.gov/study/NCT04367675" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2029-09-30", "conditions": "Extensive-stage Small Cell Lung Cancer", "enrollment": "6", "interventions": "", "nct": "NCT04397003", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Washington University School of Medicine", "startDate": "2022-03-30", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer", "url": "https://clinicaltrials.gov/study/NCT04397003" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2031-02", "conditions": "Hepatocellular Carcinoma", "enrollment": "202", "interventions": "", "nct": "NCT04727307", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "University Hospital, Montpellier", "startDate": "2021-02-23", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial", "url": "https://clinicaltrials.gov/study/NCT04727307" }, { "acronym": "GynECT", "application": "ECT", "completionDate": "2025-12-31", "conditions": "Gynecological Cancers", "enrollment": "30", "interventions": "COMBINATION_PRODUCT: Electrochemotherapy with bleomycin or cisplatin", "nct": "NCT04760327", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Institute of Oncology Ljubljana", "startDate": "2020-07-01", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "INTERVENTIONAL", "summary": "To determine the effectiveness, feasibility and safety of electrochemotherapy in treatment of local and/or regional recurrences of gynecological cancers with electrochemotherapy in which standard treatment options have been exhausted.", "title": "Electrochemotherapy of Gynecological Cancers", "url": "https://clinicaltrials.gov/study/NCT04760327" }, { "acronym": "PIONEER", "application": "Belirsiz", "completionDate": "2036-06-24", "conditions": "Skin Cancer|Gastrointestinal Cancer", "enrollment": "1000", "interventions": "", "nct": "NCT04929912", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "Mirai Medical", "startDate": "2021-06-24", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "OBSERVATIONAL", "summary": "This registry aims to assess real-world long-term disease outcomes for patients treated using reversible electroporation and a chemotherapeutic or calcium; in particular tumour response rates and recurrence rates. The study also aims to characterise side effects and the occurrence of Adverse Events and their relationship to the treatment.", "title": "Electroporation for Cancer Treatment Real World Registry", "url": "https://clinicaltrials.gov/study/NCT04929912" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2026-10-02", "conditions": "Hepatocellular Carcinoma", "enrollment": "32", "interventions": "", "nct": "NCT05113186", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Assistance Publique - Hôpitaux de Paris", "startDate": "2022-02-02", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "Neoadjuvant and Adjuvant Lenvatinib in HCC Patients Treated by Percutaneous Ablative", "url": "https://clinicaltrials.gov/study/NCT05113186" }, { "acronym": "RESPECT", "application": "ECT", "completionDate": "2028-01", "conditions": "Primary Liver Cancer|Secondary Liver Cancer", "enrollment": "250", "interventions": "DEVICE: CLINIPORATOR", "nct": "NCT05267080", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Cardiovascular and Interventional Radiological Society of Europe", "startDate": "2023-01-25", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "OBSERVATIONAL", "summary": "The Registry on Percutaneous ElectroChemoTherapy (RESPECT) is a post-market, prospective, non-randomized, observational study aiming at evaluating the effectiveness of percutaneous electrochemotherapy (ECT) for the treatment of liver cancer.", "title": "Registry on Percutaneous Electrochemotherapy", "url": "https://clinicaltrials.gov/study/NCT05267080" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2026-12", "conditions": "Cancer, Malignancy, Refractory Cancer", "enrollment": "12", "interventions": "", "nct": "NCT05302037", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "CytoMed Therapeutics Pte Ltd", "startDate": "2024-11-19", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Allogeneic NKG2DL-targeting CAR γδ T Cells (CTM-N2D) in Advanced Cancers (ANGELICA)", "url": "https://clinicaltrials.gov/study/NCT05302037" }, { "acronym": null, "application": "IRE", "completionDate": "2027-08", "conditions": "Prostate Cancer", "enrollment": "48", "interventions": "", "nct": "NCT05345444", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Weill Medical College of Cornell University", "startDate": "2022-05-26", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE)", "url": "https://clinicaltrials.gov/study/NCT05345444" }, { "acronym": "Elechtra", "application": "ECT", "completionDate": "2027-04-07", "conditions": "Vulvar Cancer", "enrollment": "92", "interventions": "DRUG: Carboplatin|DRUG: Bleomycin", "nct": "NCT05395962", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "ECT", "resultsReported": "hayir", "sponsor": "IRCCS Azienda Ospedaliero-Universitaria di Bologna", "startDate": "2022-04-08", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "INTERVENTIONAL", "summary": "Patients with vulvar cancer who underwent multiple treatments (surgery and radiation therapy or chemoradiation, radiation therapy or chemoradiation and chemotherapy), or patients not eligible for standard therapies. The study aims to: * Evaluate the oncology response to electroporation after administration of Bleomycin (BLM) + carboplatinum (CBP )to BLM alone in terms of local progression-free survival (LPFS) in women with relapsed vulvar cancer after multimodal treatments. * Compare quality of life (HR-QoL) in the two groups of patients with questionnaires (FACT-V, FACT-PAL, E5-5L-D5). * To compare Overall Survival in the two study arms. * To compare local and systemic toxicity, morbidity and mortality, intraoperative and post-operative complications among the two study arms. * To compare costs and cost-effectiveness between the two study arms.", "title": "Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer", "url": "https://clinicaltrials.gov/study/NCT05395962" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2028-04-01", "conditions": "Atrial Fibrillation", "enrollment": "60", "interventions": "", "nct": "NCT05432024", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "R&D Cardiologie", "startDate": "2023-03-08", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Evaluation of Ablation Lesions Using Cardiovascular Magnetic Resonance Imaging", "url": "https://clinicaltrials.gov/study/NCT05432024" }, { "acronym": null, "application": "Kardiyak PFA", "completionDate": "2026-09", "conditions": "Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation", "enrollment": "549", "interventions": "", "nct": "NCT05462145", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Kardium Inc.", "startDate": "2023-03-09", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation", "url": "https://clinicaltrials.gov/study/NCT05462145" }, { "acronym": "BEST", "application": "Elektroskleroterapi", "completionDate": "2022-12-01", "conditions": "Vascular Malformations", "enrollment": "20", "interventions": "OTHER: Bleomycin electrosclerotherapy treatment", "nct": "NCT05494710", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "ECT", "resultsReported": "hayir", "sponsor": "South Tees Hospitals NHS Foundation Trust", "startDate": "2020-12-01", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "INTERVENTIONAL", "summary": "The aim of the BEST study is to examine the feasibility of assessing patient and clinician reported outcome of a single electrosclerotherapy treatment of vascular malformations. * Sclerotherapy = injection of Bleomycin into vascular birthmarks to seal off abnormal vascular channels * Electroporation = application of an electric field to vessels treated with a handheld needle electrode * Electrosclerotherapy = a combination of Bleomycin sclerotherapy and electroporation", "title": "Bleomycin Electrosclerotherapy Treatment of Vascular Malformations: A Feasibility Study", "url": "https://clinicaltrials.gov/study/NCT05494710" }, { "acronym": null, "application": "Kardiyak PFA", "completionDate": "2027-08-15", "conditions": "Atrial Fibrillation", "enrollment": "1173", "interventions": "", "nct": "NCT05501873", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "Boston Scientific Corporation", "startDate": "2023-03-24", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System", "url": "https://clinicaltrials.gov/study/NCT05501873" }, { "acronym": null, "application": "IRE", "completionDate": "2027-06-01", "conditions": "Prostate Cancer", "enrollment": "184", "interventions": "", "nct": "NCT05513443", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Karolinska Institutet", "startDate": "2022-09-01", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "Prostate Cancer IRE Study (PRIS)", "url": "https://clinicaltrials.gov/study/NCT05513443" }, { "acronym": null, "application": "Kardiyak PFA", "completionDate": "2027-12-31", "conditions": "Combined Pulsed-field Ablation (PFA)", "enrollment": "200", "interventions": "", "nct": "NCT05560204", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Prince of Wales Hospital, Shatin, Hong Kong", "startDate": "2023-01-01", "status": "ENROLLING_BY_INVITATION", "statusKey": "recruiting", "statusLabel": "Davetle Alım", "studyType": "", "summary": null, "title": "Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or Amulet", "url": "https://clinicaltrials.gov/study/NCT05560204" }, { "acronym": "ELI", "application": "Kalsiyum Elektroporasyonu", "completionDate": "2025-09", "conditions": "Metastatic Colorectal Cancer", "enrollment": "12", "interventions": "DEVICE: Irreversible electroporation|DEVICE: Calcium electroporation|DRUG: Pembrolizumab", "nct": "NCT05609656", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Ismail Gögenur", "startDate": "2023-01-26", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "INTERVENTIONAL", "summary": "The trial is designed as an investigator initiated prospective phase 2 study in patients with metastatic pMMR colorectal cancer (CRC) to determine the safety and efficacy of calcium electroporation (CaEP) performed concurrently with irreversible electroporation (IRE) followed by a PD-1 inhibitor (pembrolizumab).", "title": "Electroporation and Immunotherapy in Metastatic Colorectal Cancer", "url": "https://clinicaltrials.gov/study/NCT05609656" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2029-03-09", "conditions": "Unmethylated Glioblastoma", "enrollment": "27", "interventions": "", "nct": "NCT05743595", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Washington University School of Medicine", "startDate": "2023-10-27", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma", "url": "https://clinicaltrials.gov/study/NCT05743595" }, { "acronym": null, "application": "ECT", "completionDate": "2025-12-31", "conditions": "Vulvar Cancer", "enrollment": "20", "interventions": "DRUG: Electrochemotherapy with bleomycin or cisplatin", "nct": "NCT05916690", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Institute of Oncology Ljubljana", "startDate": "2021-03-01", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "INTERVENTIONAL", "summary": "Electrochemotherapy is a local treatment modality with effectiveness comparable to other local ablation techniques. With electrochemotherapy 80% objective response can be achieved and is suitable for the treatment of different types of tumors. The method is based on increased drug delivery to cells previously exposed to electroporation. The most commonly used cytotoxic agents are bleomycin and cisplatin. The aim of the proposed clinical trial is to determine the efficacy, feasibility and safety of electrochemotherapy in the treatment of vulvar cancer.", "title": "Electrochemotherapy for the Treatment of Vulvar Cancer", "url": "https://clinicaltrials.gov/study/NCT05916690" }, { "acronym": null, "application": "Kardiyak PFA", "completionDate": "2026-03", "conditions": "Atrial Fibrillation Paroxysmal", "enrollment": "350", "interventions": "", "nct": "NCT05940597", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "University Hospital, Grenoble", "startDate": "2023-09-01", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "Pulsed Field Ablation vs Cryoablation In Paroxysmal Atrial Fibrillation", "url": "https://clinicaltrials.gov/study/NCT05940597" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2028-09-27", "conditions": "HCC - Hepatocellular Carcinoma", "enrollment": "30", "interventions": "", "nct": "NCT06045975", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Assistance Publique - Hôpitaux de Paris", "startDate": "2024-03-28", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation Procedure", "url": "https://clinicaltrials.gov/study/NCT06045975" }, { "acronym": null, "application": "Kardiyak PFA", "completionDate": "2028-12", "conditions": "Atrial Fibrillation", "enrollment": "442", "interventions": "", "nct": "NCT06099730", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Massachusetts General Hospital", "startDate": "2023-12-14", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF", "url": "https://clinicaltrials.gov/study/NCT06099730" }, { "acronym": null, "application": "Kardiyak PFA", "completionDate": "2027-05-01", "conditions": "Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation", "enrollment": "50", "interventions": "", "nct": "NCT06134752", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "University Medical Centre Ljubljana", "startDate": "2023-12-05", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "Electroporation for Treatment of Atrial Fibrillation", "url": "https://clinicaltrials.gov/study/NCT06134752" }, { "acronym": null, "application": "IRE", "completionDate": "2031-09-01", "conditions": "Colorectal Cancer, Liver Metastases, Liver Metastasis Colon Cancer", "enrollment": "78", "interventions": "", "nct": "NCT06185556", "phase": "PHASE2|PHASE3", "phaseLabel": "Faz 2/3", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Amsterdam UMC, location VUmc", "startDate": "2024-08-20", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases", "url": "https://clinicaltrials.gov/study/NCT06185556" }, { "acronym": null, "application": "IRE", "completionDate": "2030-08", "conditions": "Pancreatic Cancer", "enrollment": "18", "interventions": "", "nct": "NCT06205849", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "IRE", "resultsReported": "hayir", "sponsor": "University of California, San Diego", "startDate": "2024-07-17", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer", "url": "https://clinicaltrials.gov/study/NCT06205849" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2029-05", "conditions": "HPV Infection", "enrollment": "48", "interventions": "", "nct": "NCT06210854", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "startDate": "2026-06-25", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+", "url": "https://clinicaltrials.gov/study/NCT06210854" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2031-02", "conditions": "Prostate Cancer, Prostate Neoplasm", "enrollment": "356", "interventions": "", "nct": "NCT06223295", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Radboud University Medical Center", "startDate": "2024-02-01", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Effectiveness of Focal Therapy in Men With Prostate Cancer", "url": "https://clinicaltrials.gov/study/NCT06223295" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2026-12-31", "conditions": "Solid Tumor", "enrollment": "16", "interventions": "", "nct": "NCT06248697", "phase": "EARLY_PHASE1", "phaseLabel": "Erken Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Shanghai Cell Therapy Group Co.,Ltd", "startDate": "2023-01-01", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors", "url": "https://clinicaltrials.gov/study/NCT06248697" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2034-02-01", "conditions": "Prostate Cancer", "enrollment": "500", "interventions": "", "nct": "NCT06270043", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "University of California, San Diego", "startDate": "2024-02-01", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Focal Therapy for Localized Prostate Cancer", "url": "https://clinicaltrials.gov/study/NCT06270043" }, { "acronym": null, "application": "IRE", "completionDate": "2028-02", "conditions": "Colon Polyp", "enrollment": "30", "interventions": "", "nct": "NCT06317727", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "King's College Hospital NHS Trust", "startDate": "2025-03-26", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "PULSed Field ablAtion of coloRectal Polyps", "url": "https://clinicaltrials.gov/study/NCT06317727" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2035-12-31", "conditions": "Oligometastatic Disease, Metastases, Ablation Techniques", "enrollment": "1200", "interventions": "", "nct": "NCT06356779", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Gitte Fredberg Persson MD PhD", "startDate": "2024-04-15", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease", "url": "https://clinicaltrials.gov/study/NCT06356779" }, { "acronym": null, "application": "ECT", "completionDate": "2026-12-31", "conditions": "Cutaneous Malignant Melanoma", "enrollment": "10", "interventions": "", "nct": "NCT06388252", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Institute of Oncology Ljubljana", "startDate": "2023-11-10", "status": "ENROLLING_BY_INVITATION", "statusKey": "recruiting", "statusLabel": "Davetle Alım", "studyType": "", "summary": null, "title": "Electrochemotherapy Changes in Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Melanoma Patients", "url": "https://clinicaltrials.gov/study/NCT06388252" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2025-07-15", "conditions": "Lung Cancer", "enrollment": "15", "interventions": "", "nct": "NCT06423690", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Snipe Medical", "startDate": "2024-11-01", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "First in Human Study for the Assessment of Safety and Initial Performance of the EAS1 System", "url": "https://clinicaltrials.gov/study/NCT06423690" }, { "acronym": null, "application": "IRE", "completionDate": "2033-05", "conditions": "Prostate Cancer", "enrollment": "100", "interventions": "", "nct": "NCT06451445", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "University Health Network, Toronto", "startDate": "2024-05-16", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer", "url": "https://clinicaltrials.gov/study/NCT06451445" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2027-12-31", "conditions": "Atrial Arrhythmias", "enrollment": "35", "interventions": "", "nct": "NCT06452589", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Field Medical", "startDate": "2024-07-25", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "The Field PULSE Study", "url": "https://clinicaltrials.gov/study/NCT06452589" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2048-05-06", "conditions": "Prostate Cancer", "enrollment": "500", "interventions": "", "nct": "NCT06491056", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "Singapore General Hospital", "startDate": "2023-05-06", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)", "url": "https://clinicaltrials.gov/study/NCT06491056" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2031-05-31", "conditions": "Keratinocyte Skin Cancer", "enrollment": "1376", "interventions": "", "nct": "NCT06627036", "phase": "PHASE4", "phaseLabel": "Faz 4", "regime": null, "resultsReported": "hayir", "sponsor": "Hull University Teaching Hospitals NHS Trust", "startDate": "2024-11-21", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Dermoscopy vs Standard Marking for the Completeness of Excision of Keratinocyte Skin Cancers: The ClearMark Trial", "url": "https://clinicaltrials.gov/study/NCT06627036" }, { "acronym": null, "application": "IRE", "completionDate": "2031-08-01", "conditions": "Colorectal Cancer, Liver Metastases, Liver Metastasis Colon Cancer", "enrollment": "120", "interventions": "", "nct": "NCT06630624", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "hayir", "sponsor": "M.R. Meijerink", "startDate": "2024-07-10", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM", "url": "https://clinicaltrials.gov/study/NCT06630624" }, { "acronym": null, "application": "ECT", "completionDate": "2027-12-31", "conditions": "Cutaneous Metastasis, Cutaneous Malignant Mixed Tumor, Bleomycin Adverse Reaction", "enrollment": "55", "interventions": "", "nct": "NCT06647342", "phase": "PHASE4", "phaseLabel": "Faz 4", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Julie Gehl", "startDate": "2024-10-29", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "The Effect of Reduced Bleomycin in Electrochemotherapy Treatment", "url": "https://clinicaltrials.gov/study/NCT06647342" }, { "acronym": null, "application": "ECT", "completionDate": "2027-02-01", "conditions": "Paget Disease of the Vulva, Vulva Cancer", "enrollment": "18", "interventions": "", "nct": "NCT06715592", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS", "startDate": "2023-05-23", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study", "url": "https://clinicaltrials.gov/study/NCT06715592" }, { "acronym": null, "application": "ECT", "completionDate": "2030-02-28", "conditions": "Primary Visceral Tumors of Any Histotype, Visceral Lesions, Liver Cancer", "enrollment": "24", "interventions": "", "nct": "NCT06753136", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Istituto Oncologico Veneto IRCCS", "startDate": "2025-07-23", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype", "url": "https://clinicaltrials.gov/study/NCT06753136" }, { "acronym": null, "application": "Kardiyak PFA", "completionDate": "2027-03-30", "conditions": "Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Long-standing Persistent Atrial Fibrillation", "enrollment": "275", "interventions": "", "nct": "NCT06765356", "phase": "PHASE4", "phaseLabel": "Faz 4", "regime": null, "resultsReported": "hayir", "sponsor": "Vivek Reddy", "startDate": "2025-04-15", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias", "url": "https://clinicaltrials.gov/study/NCT06765356" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2026-05-29", "conditions": "Benign Prostatic Hyperplasia", "enrollment": "10", "interventions": "", "nct": "NCT06867315", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "First Affiliated Hospital of Zhejiang University", "startDate": "2024-05-29", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "The Safety and Effectiveness of Steep Pulse Therapy System for the Ablation of Benign Prostatic Hyperplasia", "url": "https://clinicaltrials.gov/study/NCT06867315" }, { "acronym": null, "application": "IRE", "completionDate": "2035-05-31", "conditions": "Pancreatic Cancer Non-resectable", "enrollment": "25", "interventions": "", "nct": "NCT06937996", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Englewood Hospital and Medical Center", "startDate": "2025-05-13", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-", "url": "https://clinicaltrials.gov/study/NCT06937996" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2028-06", "conditions": "Atrial Fibrillation", "enrollment": "378", "interventions": "", "nct": "NCT07021313", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "R&D Cardiologie", "startDate": "2025-06-30", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "Deliver mOre aPplications for More Durable Pulmonary Vein IsOlation", "url": "https://clinicaltrials.gov/study/NCT07021313" }, { "acronym": null, "application": "Kardiyak PFA", "completionDate": "2026-12", "conditions": "Atrial Fibrillation (AF), Atrial Fibrillation Ablation, Pulsed Field Ablation", "enrollment": "58", "interventions": "", "nct": "NCT07130773", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Cardiocentro Ticino", "startDate": "2025-11-10", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Comparative Intra-procedural Evaluation of Farapulse and FARAWAVE Nav Catheters", "url": "https://clinicaltrials.gov/study/NCT07130773" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2027-08-30", "conditions": "High-grade Squamous Intraepithelial Lesion (HSIL)", "enrollment": "150", "interventions": "", "nct": "NCT07175662", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Newish Biotech (Wuxi) Co., Ltd.", "startDate": "2025-11-11", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL", "url": "https://clinicaltrials.gov/study/NCT07175662" }, { "acronym": null, "application": "IRE", "completionDate": "2026-12-31", "conditions": "Liver Cancer, Ablation Techniques, Radiology", "enrollment": "20", "interventions": "", "nct": "NCT07214363", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "National Taiwan University Hospital", "startDate": "2023-10-01", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "The Safety and Efficacy of Irreversible Electroporation for the Treatment of Perivascular Liver Cancers", "url": "https://clinicaltrials.gov/study/NCT07214363" }, { "acronym": null, "application": "IRE", "completionDate": "2026-05-15", "conditions": "Breast Cancer", "enrollment": "24", "interventions": "", "nct": "NCT07263451", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Tian'an Jiang", "startDate": "2025-12-11", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory Study", "url": "https://clinicaltrials.gov/study/NCT07263451" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2048-09", "conditions": "Prostate Cancer", "enrollment": "130", "interventions": "", "nct": "NCT07282808", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Singapore General Hospital", "startDate": "2026-01", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Focal or Radical Therapy: a Lesion-based Molecular Evaluation in Prostate Cancer", "url": "https://clinicaltrials.gov/study/NCT07282808" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2027-04-15", "conditions": "Persistent Atrial Fibrillation", "enrollment": "40", "interventions": "", "nct": "NCT07301190", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "The Third People's Hospital of Chengdu", "startDate": "2025-06-11", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "FIH Study of PFLotus in Persistent Atrial Fibrillation", "url": "https://clinicaltrials.gov/study/NCT07301190" }, { "acronym": null, "application": "IRE", "completionDate": "2027-08-01", "conditions": "Pancreatic Adenocarcinoma Locally Advanced", "enrollment": "20", "interventions": "", "nct": "NCT07306273", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Ruijin Hospital", "startDate": "2025-12-15", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy", "url": "https://clinicaltrials.gov/study/NCT07306273" }, { "acronym": null, "application": "ECT", "completionDate": "2032-06-30", "conditions": "Bone Tumors", "enrollment": "60", "interventions": "", "nct": "NCT07323017", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Costantino Errani", "startDate": "2025-08-01", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "Electrochemotherapy in Musculoskeletal Tumors", "url": "https://clinicaltrials.gov/study/NCT07323017" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2028-12-31", "conditions": "Hepatocellular Carcinoma (HCC)", "enrollment": "30", "interventions": "", "nct": "NCT07324304", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Newish Technology (Beijing) Co., Ltd.", "startDate": "2025-12-08", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "NWRD06 DNA Plasmid for HCC After Curative Resection.", "url": "https://clinicaltrials.gov/study/NCT07324304" }, { "acronym": null, "application": "IRE", "completionDate": "2028-06", "conditions": "Thyroid Cancer Patients, Lymph Node Metastasis", "enrollment": "85", "interventions": "", "nct": "NCT07328243", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Tian'an Jiang", "startDate": "2025-12-17", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Irreversible Electroporation for Recurrent or Metastatic Cervical Lymph Node Metastases From Thyroid Cancer: A Prospective Multicenter Single-Arm Study", "url": "https://clinicaltrials.gov/study/NCT07328243" }, { "acronym": null, "application": "ECT", "completionDate": "2026-09-30", "conditions": "MELANOMA, SKIN NEOPLASMS", "enrollment": "150", "interventions": "", "nct": "NCT07404605", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Institute of Oncology Ljubljana", "startDate": "2023-09-01", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma", "url": "https://clinicaltrials.gov/study/NCT07404605" }, { "acronym": null, "application": "ECT", "completionDate": "2026-08-31", "conditions": "Vulvar Cancer, Recurrent Vulvar Cancer", "enrollment": "13", "interventions": "", "nct": "NCT07443475", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Institute of Oncology Ljubljana", "startDate": "2021-09-01", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Electrochemotherapy for Recurrent Vulvar Cancer", "url": "https://clinicaltrials.gov/study/NCT07443475" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2028-06", "conditions": "Cervical Intraepithelial Neoplasia Grade 2/3, Human Papilloma Virus Infection Type 16", "enrollment": "138", "interventions": "", "nct": "NCT07454915", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "PapiVax Biotech, Inc.", "startDate": "2026-04-01", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia", "url": "https://clinicaltrials.gov/study/NCT07454915" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2029-04-16", "conditions": "Prostate Cancer", "enrollment": "224", "interventions": "", "nct": "NCT07548164", "phase": "PHASE3", "phaseLabel": "Faz 3", "regime": null, "resultsReported": "hayir", "sponsor": "Memorial Sloan Kettering Cancer Center", "startDate": "2026-04-16", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer", "url": "https://clinicaltrials.gov/study/NCT07548164" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2040-12-31", "conditions": "Prostate Cancer", "enrollment": "1000", "interventions": "", "nct": "NCT07623941", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "Columbia University", "startDate": "2026-01-01", "status": "RECRUITING", "statusKey": "recruiting", "statusLabel": "Hasta Alıyor", "studyType": "", "summary": null, "title": "CUIMC Focal Therapy Registry", "url": "https://clinicaltrials.gov/study/NCT07623941" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2026-12-31", "conditions": "Malignant Pulmonary Nodules, Lung Cancer", "enrollment": "5", "interventions": "", "nct": "NCT07638228", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Sir Run Run Shaw Hospital", "startDate": "2025-09-01", "status": "ACTIVE_NOT_RECRUITING", "statusKey": "recruiting", "statusLabel": "Aktif, Alım Yok", "studyType": "", "summary": null, "title": "Evaluation of the Safety and Efficacy of a Wideband Electric Pulse Tumor Ablation System for Malignant Pulmonary Nodules", "url": "https://clinicaltrials.gov/study/NCT07638228" }, { "acronym": null, "application": "ECT", "completionDate": "2008-09", "conditions": "Head and Neck Cancer", "enrollment": "95", "interventions": "", "nct": "NCT00198263", "phase": "PHASE4", "phaseLabel": "Faz 4", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Inovio Pharmaceuticals", "startDate": "2004-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer", "url": "https://clinicaltrials.gov/study/NCT00198263" }, { "acronym": null, "application": "ECT", "completionDate": "2008-09", "conditions": "Cancer", "enrollment": "88", "interventions": "", "nct": "NCT00198276", "phase": "PHASE4", "phaseLabel": "Faz 4", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Inovio Pharmaceuticals", "startDate": "2004-02", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer", "url": "https://clinicaltrials.gov/study/NCT00198276" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2008-10", "conditions": "Metastatic Melanoma", "enrollment": "26", "interventions": "", "nct": "NCT00223899", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Vical", "startDate": "2005-07", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "A Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic Melanoma", "url": "https://clinicaltrials.gov/study/NCT00223899" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2008-04", "conditions": "Malignant Melanoma", "enrollment": "24", "interventions": "", "nct": "NCT00323206", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "H. Lee Moffitt Cancer Center and Research Institute", "startDate": "2004-06", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma", "url": "https://clinicaltrials.gov/study/NCT00323206" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2010-05", "conditions": "Melanoma (Skin), Intraocular Melanoma", "enrollment": "24", "interventions": "", "nct": "NCT00471133", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Ichor Medical Systems Incorporated", "startDate": "2007-04", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation", "url": "https://clinicaltrials.gov/study/NCT00471133" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2011-03", "conditions": "Papillomavirus Infections", "enrollment": "18", "interventions": "", "nct": "NCT00685412", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Inovio Pharmaceuticals", "startDate": "2008-05", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3", "url": "https://clinicaltrials.gov/study/NCT00685412" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2011-04", "conditions": "Non-Small Cell Lung Carcinoma, Breast Cancer, Melanoma", "enrollment": "37", "interventions": "", "nct": "NCT00753415", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "EVET", "sponsor": "Merck Sharp & Dohme LLC", "startDate": "2008-08", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)", "url": "https://clinicaltrials.gov/study/NCT00753415" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2011-11", "conditions": "Prostate Cancer", "enrollment": "15", "interventions": "", "nct": "NCT00859729", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "hayir", "sponsor": "Uppsala University", "startDate": "2008-12", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Dose Finding Study of a DNA Vaccine Delivered With Intradermal Electroporation in Patients With Prostate Cancer", "url": "https://clinicaltrials.gov/study/NCT00859729" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2016-08", "conditions": "Colorectal Cancer", "enrollment": "16", "interventions": "", "nct": "NCT01064375", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "hayir", "sponsor": "Maria Liljefors", "startDate": "2009-12", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Safety Study of DNA Vaccine Delivered by Intradermal Electroporation to Treat Colorectal Cancer", "url": "https://clinicaltrials.gov/study/NCT01064375" }, { "acronym": null, "application": "IRE", "completionDate": "2013-06", "conditions": "Carcinoma, Hepatocellular", "enrollment": "26", "interventions": "", "nct": "NCT01078415", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Angiodynamics, Inc.", "startDate": "2010-02", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)", "url": "https://clinicaltrials.gov/study/NCT01078415" }, { "acronym": "CCEE EndoVe", "application": "Belirsiz", "completionDate": "2016-09", "conditions": "Colorectal Cancer", "enrollment": "10", "interventions": "DEVICE: EndoVe endoscopic electroporation", "nct": "NCT01172860", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Mercy University Hospital, Cork, Ireland", "startDate": "2010-03", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "INTERVENTIONAL", "summary": "A new approach to treating solid tumours (both operable and inoperable) has been carried out by the Cork Cancer Research Centre (CCRC) at the Mercy University Hospital, Cork, Ireland since 2002. The approach simply allows a greater concentration of chemotherapy drugs to enter the tumour cells rather than healthy cells. The uptake of the chemotherapeutic drug directly by the tumour is aided through applying short electric pulses to the tumor mass (referred to as - Electrochemotherapy or ECT). The pulses make the tumour more porous which allows the drug easier access into the cancer cells, whereas other tissues and organs in the body remain relatively poor at absorbing the drug, thereby reducing the potential side effects on healthy tissues. This approach to date has been limited to skin based tumours due to the requirement for the electrodes to be placed directly in contact with the tumou", "title": "Endoscopic Treatment of Inoperable Colorectal Cancer With the EndoVe System", "url": "https://clinicaltrials.gov/study/NCT01172860" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2011-10-20", "conditions": "Human Papillomavirus (HPV)", "enrollment": "14", "interventions": "", "nct": "NCT01188850", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Inovio Pharmaceuticals", "startDate": "2010-07", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated With Three Doses of VGX-3100", "url": "https://clinicaltrials.gov/study/NCT01188850" }, { "acronym": "ECTJ", "application": "ECT", "completionDate": "2013-11", "conditions": "Liver Metastases", "enrollment": "16", "interventions": "PROCEDURE: Electrochemotherapy", "nct": "NCT01264952", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": "ECT", "resultsReported": "EVET", "sponsor": "Institute of Oncology Ljubljana", "startDate": "2008-11", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "INTERVENTIONAL", "summary": "The aim of the study is to evaluate toxicity and effectiveness of electrochemotherapy with bleomycin in treatment of liver metastases of colorectal cancer in clinical study phase I and II. The study will include 10-15 patients with colorectal cancer with synchronous or metachronous liver metastases, but electrochemotherapy will be performed on metastasis not more than 3 cm in the largest diameter. Treatment effectiveness will be evaluated by magnetic resonance imaging (MRI) and ultrasonography (US) in a monthly interval. Two or three month after the first operation the treated and untreated metastases will be resected and through histological analyses performed. The secondary objectives of the trial are to quantify the impact of the treatment on the patient's quality of life, tolerance to the therapy and suitability for larger study to be conducted.", "title": "Treatment of Liver Metastases With Electrochemotherapy", "url": "https://clinicaltrials.gov/study/NCT01264952" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2015-04", "conditions": "Cervical Intraepithelial Neoplasia", "enrollment": "167", "interventions": "", "nct": "NCT01304524", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Inovio Pharmaceuticals", "startDate": "2011-04", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3", "url": "https://clinicaltrials.gov/study/NCT01304524" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2010-05-27", "conditions": "Intradermal Electroporation", "enrollment": "24", "interventions": "", "nct": "NCT01324843", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "National Institute on Aging (NIA)", "startDate": "2009-06-25", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Safety and Tolerability of the Derma Vax(Trademark) Clinical Intradermal Electroporation System in Healthy Subjects", "url": "https://clinicaltrials.gov/study/NCT01324843" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2013-02-26", "conditions": "Leukaemia (Acute), Leukaemia (Chronic), Leukaemia (Acute Myeloid)", "enrollment": "23", "interventions": "", "nct": "NCT01334060", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "University Hospital Southampton NHS Foundation Trust", "startDate": "2011-02-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation", "url": "https://clinicaltrials.gov/study/NCT01334060" }, { "acronym": null, "application": "IRE", "completionDate": "2012-09", "conditions": "Pancreatic Adenocarcinoma", "enrollment": "10", "interventions": "", "nct": "NCT01369420", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Angiodynamics, Inc.", "startDate": "2011-05", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT01369420" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2015-04-10", "conditions": "Merkel Cell Carcinoma", "enrollment": "15", "interventions": "", "nct": "NCT01440816", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "EVET", "sponsor": "OncoSec Medical Incorporated", "startDate": "2012-01-03", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "IL-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Patients With Merkel Cell Cancer", "url": "https://clinicaltrials.gov/study/NCT01440816" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2023-01-12", "conditions": "Melanoma", "enrollment": "9", "interventions": "", "nct": "NCT01456104", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Memorial Sloan Kettering Cancer Center", "startDate": "2011-10-17", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma", "url": "https://clinicaltrials.gov/study/NCT01456104" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2016-03-21", "conditions": "Melanoma", "enrollment": "51", "interventions": "", "nct": "NCT01502293", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "EVET", "sponsor": "OncoSec Medical Incorporated", "startDate": "2012-02-14", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Trial of pIL-12 Electroporation Malignant Melanoma", "url": "https://clinicaltrials.gov/study/NCT01502293" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2014-11", "conditions": "Melanoma", "enrollment": "28", "interventions": "", "nct": "NCT01530698", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "hayir", "sponsor": "Radboud University Medical Center", "startDate": "2010-04", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients", "url": "https://clinicaltrials.gov/study/NCT01530698" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2014-01", "conditions": "Cancer", "enrollment": "26", "interventions": "", "nct": "NCT01563679", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "Emory University", "startDate": "2012-02", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Analysis of Percutaneous Ablations for Cancer Treatment", "url": "https://clinicaltrials.gov/study/NCT01563679" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2014-02", "conditions": "Cervical Intraepithelial Neoplasia 3", "enrollment": "9", "interventions": "", "nct": "NCT01634503", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Genexine, Inc.", "startDate": "2012-11", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3", "url": "https://clinicaltrials.gov/study/NCT01634503" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2016-09", "conditions": "Malignant Melanoma Stage III, Malignant Melanoma Stage IV", "enrollment": "88", "interventions": "", "nct": "NCT01676779", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Universitair Ziekenhuis Brussel", "startDate": "2012-10", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma", "url": "https://clinicaltrials.gov/study/NCT01676779" }, { "acronym": null, "application": "IRE", "completionDate": "2014-10", "conditions": "Prostate Cancer", "enrollment": "16", "interventions": "", "nct": "NCT01790451", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Clinical Research Office of the Endourological Society", "startDate": "2013-08", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Safety and Efficacy of Irreversible Electroporation in Ablation of Prostate Cancer in Humans", "url": "https://clinicaltrials.gov/study/NCT01790451" }, { "acronym": null, "application": "IRE", "completionDate": "2013-09", "conditions": "Colorectal Liver Metastases, Metastatic Liver Disease", "enrollment": "10", "interventions": "", "nct": "NCT01799044", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Dr. M.R. Meijerink", "startDate": "2012-11", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Pilot-study: Non-thermal Ablation Using Irreversible Electroporation to Treat Colorectal Liver Metastases", "url": "https://clinicaltrials.gov/study/NCT01799044" }, { "acronym": null, "application": "IRE", "completionDate": "2016-10", "conditions": "Locally Advanced Pancreatic Carcinoma (LAPC), Non-metastasized Unresectable Pancreatic Carcinoma, Pancreatic Cancer", "enrollment": "50", "interventions": "", "nct": "NCT01939665", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Amsterdam UMC, location VUmc", "startDate": "2013-09", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "PANFIRE Study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma", "url": "https://clinicaltrials.gov/study/NCT01939665" }, { "acronym": null, "application": "Kalsiyum Elektroporasyonu", "completionDate": "2017-01-23", "conditions": "Cutaneous Metastases", "enrollment": "7", "interventions": "DRUG: Calcium electroporation|DRUG: Electrochemotherapy with bleomycin", "nct": "NCT01941901", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Herlev Hospital", "startDate": "2013-09", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "INTERVENTIONAL", "summary": "The purpose of this study is to evaluate the effect of calcium electroporation on cutaneous metastases, and compare calcium electroporation with standard treatment: electrochemotherapy.", "title": "Calcium Electroporation for Treatment of Cutaneous Metastases", "url": "https://clinicaltrials.gov/study/NCT01941901" }, { "acronym": null, "application": "Kalsiyum Elektroporasyonu", "completionDate": "2018-05-01", "conditions": "Keloid", "enrollment": "7", "interventions": "", "nct": "NCT01941914", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Herlev Hospital", "startDate": "2013-08", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Calcium Electroporation for the Treatment of Keloids", "url": "https://clinicaltrials.gov/study/NCT01941914" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2022-06-20", "conditions": "Multiple Myeloma", "enrollment": "28", "interventions": "", "nct": "NCT01995708", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "EVET", "sponsor": "Memorial Sloan Kettering Cancer Center", "startDate": "2014-01-31", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation", "url": "https://clinicaltrials.gov/study/NCT01995708" }, { "acronym": null, "application": "IRE", "completionDate": "2013-12", "conditions": "Malignant Liver Tumors", "enrollment": "20", "interventions": "", "nct": "NCT02010801", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "National Taiwan University Hospital", "startDate": "2012-04", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors", "url": "https://clinicaltrials.gov/study/NCT02010801" }, { "acronym": null, "application": "IRE", "completionDate": "2019-05-01", "conditions": "Pancreatic Cancer", "enrollment": "33", "interventions": "", "nct": "NCT02079623", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Aalborg University Hospital", "startDate": "2013-11", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Electroporation (NanoKnife) as Treatment for Advanced Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT02079623" }, { "acronym": null, "application": "IRE", "completionDate": "2020-05", "conditions": "Colorectal Liver Metastases", "enrollment": "51", "interventions": "", "nct": "NCT02082782", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Amsterdam UMC, location VUmc", "startDate": "2014-05", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Efficacy of Irreversible Electroporation (IRE) for Central Colorectal Liver Metastases", "url": "https://clinicaltrials.gov/study/NCT02082782" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2016-03", "conditions": "Cervical Intraepithelial Neoplasia", "enrollment": "72", "interventions": "", "nct": "NCT02139267", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Genexine, Inc.", "startDate": "2014-07", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia", "url": "https://clinicaltrials.gov/study/NCT02139267" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2017-01-23", "conditions": "Head and Neck Squamous Cell Cancer", "enrollment": "22", "interventions": "", "nct": "NCT02163057", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "EVET", "sponsor": "Inovio Pharmaceuticals", "startDate": "2014-08-13", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma", "url": "https://clinicaltrials.gov/study/NCT02163057" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2017-09-07", "conditions": "Cervical Cancer", "enrollment": "10", "interventions": "", "nct": "NCT02172911", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "EVET", "sponsor": "Inovio Pharmaceuticals", "startDate": "2014-06-06", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "A Study of INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer", "url": "https://clinicaltrials.gov/study/NCT02172911" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2018-09", "conditions": "Aerodigestive Precancerous Lesions and Malignancies", "enrollment": "3", "interventions": "", "nct": "NCT02241369", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Inovio Pharmaceuticals", "startDate": "2014-05", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Immunotherapy in Subjects With HPV-6 Associated Aerodigestive Precancerous Lesions and Malignancies", "url": "https://clinicaltrials.gov/study/NCT02241369" }, { "acronym": "ECT-HCC", "application": "ECT", "completionDate": "2020-01", "conditions": "Liver Cancer", "enrollment": "25", "interventions": "PROCEDURE: Electrochemotherapy|DEVICE: Cliniporator Vitae®|DRUG: Bleomycin PHC 15 e. (United States Pharmacopeia - USP)", "nct": "NCT02291133", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": "ECT", "resultsReported": "EVET", "sponsor": "Masa Bosnjak", "startDate": "2014-06", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "INTERVENTIONAL", "summary": "The aim of the study is to evaluate toxicity and effectiveness of electrochemotherapy with bleomycin in treatment of primary liver tumors in clinical study phase I and II. The study will include 10 patients in phase I clinical study and additional 15 patients in phase II clinical study (or in the extension of the clinical study), which will fulfill inclusion criteria. Treatment effectiveness will be evaluated by DCE-US or CT perfusion, to detect early events in tumor perfusion after ECT compared to tumor perfusion before ECT. Long term effectiveness of the treatment will be evaluated by modified RECIST criteria, which will take into account difference in size and density, determined from images obtained by CT perfusion of the treated tumor nodules before and after ECT. Tumor volume will be calculated by following formula , where a will be shorter and b longer tumor diameter. The secondar", "title": "Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)", "url": "https://clinicaltrials.gov/study/NCT02291133" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2018-06-01", "conditions": "Solid Tumors", "enrollment": "26", "interventions": "", "nct": "NCT02301754", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Invectys", "startDate": "2014-11", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "INVAC-1 Anti-Cancer hTERT DNA Immunotherapy", "url": "https://clinicaltrials.gov/study/NCT02301754" }, { "acronym": null, "application": "IRE", "completionDate": "2021-01-01", "conditions": "Liver Cancer", "enrollment": "30", "interventions": "", "nct": "NCT02329106", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2014-12-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome", "url": "https://clinicaltrials.gov/study/NCT02329106" }, { "acronym": null, "application": "IRE", "completionDate": "2021-08-01", "conditions": "Hepatic Carcinoma", "enrollment": "30", "interventions": "", "nct": "NCT02332551", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Percutaneous Irreversible Electroporation to Treat Liver Cancer Close to the Gallbladder", "url": "https://clinicaltrials.gov/study/NCT02332551" }, { "acronym": null, "application": "IRE", "completionDate": "2021-01-01", "conditions": "Liver Cancer", "enrollment": "15", "interventions": "", "nct": "NCT02333773", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli", "url": "https://clinicaltrials.gov/study/NCT02333773" }, { "acronym": null, "application": "IRE", "completionDate": "2021-01-01", "conditions": "Head and Neck Neoplasms", "enrollment": "15", "interventions": "", "nct": "NCT02335112", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms", "url": "https://clinicaltrials.gov/study/NCT02335112" }, { "acronym": null, "application": "IRE", "completionDate": "2021-01-01", "conditions": "Renal Tumor", "enrollment": "15", "interventions": "", "nct": "NCT02335827", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Irreversible Electroporation(IRE) For Unresectable Renal Tumors", "url": "https://clinicaltrials.gov/study/NCT02335827" }, { "acronym": null, "application": "IRE", "completionDate": "2021-01-01", "conditions": "Breast Cancer", "enrollment": "30", "interventions": "", "nct": "NCT02340858", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Percutaneous Irreversible Electroportion for Unresectable Breast Cancer", "url": "https://clinicaltrials.gov/study/NCT02340858" }, { "acronym": null, "application": "IRE", "completionDate": "2021-05-01", "conditions": "Pancreatic Cancer", "enrollment": "20", "interventions": "", "nct": "NCT02343835", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT02343835" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2020-03-12", "conditions": "Triple Negative Breast Cancer, Triple-Negative Breast Cancer, Triple Negative Breast Neoplasms", "enrollment": "18", "interventions": "", "nct": "NCT02348320", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Washington University School of Medicine", "startDate": "2015-06-17", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Safety and Immunogenicity of a Personalized Polyepitope DNA Vaccine Strategy in Breast Cancer Patients With Persistent Triple-Negative Disease Following Neoadjuvant Chemotherapy", "url": "https://clinicaltrials.gov/study/NCT02348320" }, { "acronym": null, "application": "ECT", "completionDate": "2018-10", "conditions": "Liver Metastases", "enrollment": "23", "interventions": "PROCEDURE: Electrochemotherapy|DEVICE: Cliniporator Vitae®|DRUG: Bleomycin PHC 15 e. (United States Pharmacopeia - USP)", "nct": "NCT02352259", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "ECT", "resultsReported": "EVET", "sponsor": "Institute of Oncology Ljubljana", "startDate": "2013-09", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "INTERVENTIONAL", "summary": "The study is prospective, phase II study, The primary objective of the study is evaluation of the feasibility and safety of intraoperative electrochemotherapy of colorectal liver metastases. The secondary objective is to determine the efficacy of electrochemotherapy treatment, based on histological and radiological evaluation of treated metastases. The endpoints are: toxicity according to the Common Terminology Criteria for Adverse Events (CTCAE) ver. 4.0 and response rate measured by percentage of vital tumor cells and mRECIST criteria.", "title": "Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II", "url": "https://clinicaltrials.gov/study/NCT02352259" }, { "acronym": null, "application": "IRE", "completionDate": "2021-01-01", "conditions": "Hepatic Carcinoma", "enrollment": "15", "interventions": "", "nct": "NCT02352935", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Percutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver Function", "url": "https://clinicaltrials.gov/study/NCT02352935" }, { "acronym": null, "application": "IRE", "completionDate": "2021-02-01", "conditions": "Rectal Neoplasms", "enrollment": "30", "interventions": "", "nct": "NCT02425059", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms", "url": "https://clinicaltrials.gov/study/NCT02425059" }, { "acronym": null, "application": "IRE", "completionDate": "2021-03-01", "conditions": "Hilus Pulmonary Neoplasms", "enrollment": "30", "interventions": "", "nct": "NCT02430597", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Irreversible Electroporation(IRE) For Unresectable Hilus Pulmonis Neoplasms", "url": "https://clinicaltrials.gov/study/NCT02430597" }, { "acronym": null, "application": "IRE", "completionDate": "2021-02-01", "conditions": "Uterine Cervical Neoplasms", "enrollment": "30", "interventions": "", "nct": "NCT02430610", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Irreversible Electroporation(IRE) For Uterine Cervical Neoplasms", "url": "https://clinicaltrials.gov/study/NCT02430610" }, { "acronym": null, "application": "IRE", "completionDate": "2021-03-01", "conditions": "Urinary Bladder Neoplasms", "enrollment": "30", "interventions": "", "nct": "NCT02430623", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms", "url": "https://clinicaltrials.gov/study/NCT02430623" }, { "acronym": null, "application": "IRE", "completionDate": "2021-02-01", "conditions": "Stomach Neoplasms", "enrollment": "30", "interventions": "", "nct": "NCT02430636", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Irreversible Electroporation(IRE) For Unresectable Stomach Neoplasms", "url": "https://clinicaltrials.gov/study/NCT02430636" }, { "acronym": null, "application": "IRE", "completionDate": "2021-03-01", "conditions": "Gallbladder Neoplasms", "enrollment": "30", "interventions": "", "nct": "NCT02430662", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms", "url": "https://clinicaltrials.gov/study/NCT02430662" }, { "acronym": null, "application": "IRE", "completionDate": "2021-01-01", "conditions": "Laryngeal Neoplasms", "enrollment": "30", "interventions": "", "nct": "NCT02430675", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms", "url": "https://clinicaltrials.gov/study/NCT02430675" }, { "acronym": null, "application": "IRE", "completionDate": "2021-02-01", "conditions": "Extremities Neoplasms", "enrollment": "30", "interventions": "", "nct": "NCT02430688", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Irreversible Electroporation(IRE) For Unresectable Extremities Neoplasms", "url": "https://clinicaltrials.gov/study/NCT02430688" }, { "acronym": null, "application": "IRE", "completionDate": "2021-04-01", "conditions": "Esophageal Neoplasms", "enrollment": "30", "interventions": "", "nct": "NCT02430701", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Irreversible Electroporation(IRE) For Unresectable Esophageal Neoplasms", "url": "https://clinicaltrials.gov/study/NCT02430701" }, { "acronym": null, "application": "IRE", "completionDate": "2021-02-01", "conditions": "Lung Neoplasms Accompanied by Respiratory Function Insufficiency", "enrollment": "30", "interventions": "", "nct": "NCT02430753", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Irreversible Electroporation(IRE) For Lung Neoplasms Accompanied by Respiratory Function Insufficiency", "url": "https://clinicaltrials.gov/study/NCT02430753" }, { "acronym": null, "application": "IRE", "completionDate": "2021-02-01", "conditions": "Lymph Node Metastases", "enrollment": "30", "interventions": "", "nct": "NCT02430766", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Irreversible Electroporation(IRE) For Unresectable Lymph Node Metastases(Close to Nerve)", "url": "https://clinicaltrials.gov/study/NCT02430766" }, { "acronym": null, "application": "IRE", "completionDate": "2021-01-01", "conditions": "Renal Pelvic and Ureteral Neoplasms", "enrollment": "30", "interventions": "", "nct": "NCT02430779", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Irreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral Neoplasms", "url": "https://clinicaltrials.gov/study/NCT02430779" }, { "acronym": null, "application": "IRE", "completionDate": "2017-02", "conditions": "Colorectal Metastases to the Lung", "enrollment": "2", "interventions": "", "nct": "NCT02461550", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "EVET", "sponsor": "Memorial Sloan Kettering Cancer Center", "startDate": "2015-05", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Irreversible Electroporation Ablation for Colorectal Metastases to the Lung", "url": "https://clinicaltrials.gov/study/NCT02461550" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2020-03-02", "conditions": "Melanoma", "enrollment": "24", "interventions": "", "nct": "NCT02493361", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "EVET", "sponsor": "University of California, San Francisco", "startDate": "2015-08-17", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Trial of pIL-12/MK-3475 in Metastatic Melanoma", "url": "https://clinicaltrials.gov/study/NCT02493361" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2017-12-12", "conditions": "Prostate Cancer", "enrollment": "62", "interventions": "", "nct": "NCT02514213", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Inovio Pharmaceuticals", "startDate": "2015-07", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer", "url": "https://clinicaltrials.gov/study/NCT02514213" }, { "acronym": null, "application": "ECT", "completionDate": "2017-04-18", "conditions": "Pancreatic Adenocarcinoma", "enrollment": "6", "interventions": "DEVICE: Electroporation|DRUG: gemcitabine|DRUG: nab-paclitaxel", "nct": "NCT02514421", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "ECT", "resultsReported": "hayir", "sponsor": "The University of Texas Health Science Center, Houston", "startDate": "2015-07", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "INTERVENTIONAL", "summary": "The purpose of this study is to see how well electrochemotherapy works at treating people with Stage III pancreatic adenocarcinoma. Electrochemotherapy is a treatment that combines electroporation and chemotherapy administration. Electroporation uses an electric current to produce holes in pancreatic tumor, which causes the tumor cells to die or take up a higher concentration of administered chemotherapy agent. This study will test the safety and look at the effect of electrochemotherapy in the treatment of stage III pancreatic adenocarcinoma. This study will also help to find the safest and most effective amount of electroporation voltage to apply to this type of tumor.", "title": "Evaluation of Safety and Efficacy of Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma", "url": "https://clinicaltrials.gov/study/NCT02514421" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2018-07", "conditions": "ER-Negative PR-Negative HER2-Negative Breast Cancer", "enrollment": "10", "interventions": "", "nct": "NCT02531425", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "OncoSec Medical Incorporated", "startDate": "2015-09", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Evaluation of Pharmacodynamic Effects of IT-pIL12-EP in Patients With TNBC", "url": "https://clinicaltrials.gov/study/NCT02531425" }, { "acronym": null, "application": "IRE", "completionDate": "2019-03-01", "conditions": "Pancreatic Cancer", "enrollment": "60", "interventions": "", "nct": "NCT02718859", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2016-03-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT02718859" }, { "acronym": null, "application": "IRE", "completionDate": "2022-09", "conditions": "Pancreatic Neoplasm", "enrollment": "74", "interventions": "", "nct": "NCT02791503", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Dr. M.R. Meijerink", "startDate": "2016-05-30", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "CROSSFIRE Trial: Comparing the Efficacy of Irreversible Electroporation With Radiotherapy", "url": "https://clinicaltrials.gov/study/NCT02791503" }, { "acronym": null, "application": "IRE", "completionDate": "2020-05-27", "conditions": "Hepatocellular Carcinoma, Metastatic Liver Cancers", "enrollment": "18", "interventions": "", "nct": "NCT02828865", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "National Taiwan University Hospital", "startDate": "2012-11", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers", "url": "https://clinicaltrials.gov/study/NCT02828865" }, { "acronym": null, "application": "IRE", "completionDate": "2020-05-27", "conditions": "Pancreatic Cancer", "enrollment": "7", "interventions": "", "nct": "NCT02841436", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "National Taiwan University Hospital", "startDate": "2012-11", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "A Clinical Research About Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT02841436" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2018-11-09", "conditions": "Breast Cancer, Lung Cancer, Pancreatic Cancer", "enrollment": "93", "interventions": "", "nct": "NCT02960594", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Inovio Pharmaceuticals", "startDate": "2014-12", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse", "url": "https://clinicaltrials.gov/study/NCT02960594" }, { "acronym": null, "application": "IRE", "completionDate": "2020-10-01", "conditions": "Pancreatic Cancer", "enrollment": "61", "interventions": "", "nct": "NCT02981719", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2016-10-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT02981719" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2023-01-06", "conditions": "Pancreatic Cancer, Surgery", "enrollment": "33", "interventions": "", "nct": "NCT03001518", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "Duke University", "startDate": "2017-05-04", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Immunologic Signatures Following Surgery for Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT03001518" }, { "acronym": null, "application": "IRE", "completionDate": "2019-07-01", "conditions": "Recurrent Liver Carcinoma", "enrollment": "20", "interventions": "", "nct": "NCT03008343", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2016-12-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer", "url": "https://clinicaltrials.gov/study/NCT03008343" }, { "acronym": null, "application": "IRE", "completionDate": "2021-04-01", "conditions": "Pancreatic Adenocarcinoma, Interventional Imaging", "enrollment": "20", "interventions": "", "nct": "NCT03105921", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Poitiers University Hospital", "startDate": "2014-10-24", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Irreversible Electroporation (NanoKnife) for the Treatment of Pancreatic Adenocarcinoma", "url": "https://clinicaltrials.gov/study/NCT03105921" }, { "acronym": null, "application": "ECT", "completionDate": "2019-12-31", "conditions": "Advanced Inoperable Vulva Carcinoma", "enrollment": "50", "interventions": "PROCEDURE: Electrochemotherapy", "nct": "NCT03142061", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "ECT", "resultsReported": "hayir", "sponsor": "University Women's Hospital Tübingen", "startDate": "2017-06-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "INTERVENTIONAL", "summary": "Electrochemotherapy (ECT) with Bleomycin in non-operable advanced vulva carcinoma", "title": "Electrochemotherapy for the Inoperable Vulva Carcinoma", "url": "https://clinicaltrials.gov/study/NCT03142061" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2021-03-19", "conditions": "Head and Neck Cancer, Human Papilloma Virus", "enrollment": "35", "interventions": "", "nct": "NCT03162224", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "EVET", "sponsor": "MedImmune LLC", "startDate": "2017-06-26", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Safety and Efficacy of MEDI0457 and Durvalumab in Participants With Human Papilloma Virus (HPV) Associated Recurrent/Metastatic Head and Neck Cancer", "url": "https://clinicaltrials.gov/study/NCT03162224" }, { "acronym": null, "application": "IRE", "completionDate": "2019-06-15", "conditions": "Pancreatic Cancer", "enrollment": "62", "interventions": "", "nct": "NCT03180437", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2017-06-15", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT03180437" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2020-12-18", "conditions": "Vulvar High Grade Squamous Intraepithelial Lesion (HSIL), Vulvar Dysplasia, Vulvar Intraepithelial Neoplasia (VIN)", "enrollment": "33", "interventions": "", "nct": "NCT03180684", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "EVET", "sponsor": "Inovio Pharmaceuticals", "startDate": "2017-08-31", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)", "url": "https://clinicaltrials.gov/study/NCT03180684" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2019-06-15", "conditions": "Liver Cancer", "enrollment": "30", "interventions": "", "nct": "NCT03183219", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2017-06-15", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Safety and Efficiency of γδ T Cell Against Liver Cancer", "url": "https://clinicaltrials.gov/study/NCT03183219" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2019-06-15", "conditions": "Lung Cancer", "enrollment": "30", "interventions": "", "nct": "NCT03183232", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2017-06-15", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Safety and Efficiency of γδ T Cell Against Lung Cancer", "url": "https://clinicaltrials.gov/study/NCT03183232" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2021-04-06", "conditions": "Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion, HSIL", "enrollment": "201", "interventions": "", "nct": "NCT03185013", "phase": "PHASE3", "phaseLabel": "Faz 3", "regime": null, "resultsReported": "EVET", "sponsor": "Inovio Pharmaceuticals", "startDate": "2017-06-28", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)", "url": "https://clinicaltrials.gov/study/NCT03185013" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2018-09-02", "conditions": "Liver, Cancer of, Non-Resectable", "enrollment": "120", "interventions": "", "nct": "NCT03239158", "phase": "PHASE2|PHASE3", "phaseLabel": "Faz 2/3", "regime": null, "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2017-09-02", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Bioinformation Therapy for Liver Cancer", "url": "https://clinicaltrials.gov/study/NCT03239158" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2018-09-02", "conditions": "Small-cell Lung Cancer", "enrollment": "120", "interventions": "", "nct": "NCT03239171", "phase": "PHASE2|PHASE3", "phaseLabel": "Faz 2/3", "regime": null, "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2017-09-02", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Bioinformation Therapy for Lung Cancer", "url": "https://clinicaltrials.gov/study/NCT03239171" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2018-09-01", "conditions": "Unresectable Pancreatic Cancer", "enrollment": "120", "interventions": "", "nct": "NCT03239184", "phase": "PHASE2|PHASE3", "phaseLabel": "Faz 2/3", "regime": null, "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2017-09-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Bioinformation Therapy for Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT03239184" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2018-09-02", "conditions": "Advanced Breast Cancer", "enrollment": "120", "interventions": "", "nct": "NCT03240224", "phase": "PHASE2|PHASE3", "phaseLabel": "Faz 2/3", "regime": null, "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2017-09-02", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Bioinformation Therapy for Breast Cancer", "url": "https://clinicaltrials.gov/study/NCT03240224" }, { "acronym": null, "application": "IRE", "completionDate": "2022-07-14", "conditions": "Pancreatic Ductal Adenocarcinoma", "enrollment": "12", "interventions": "", "nct": "NCT03257150", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "University Health Network, Toronto", "startDate": "2017-09-22", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer", "url": "https://clinicaltrials.gov/study/NCT03257150" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2017-10-27", "conditions": "Prostate Cancer", "enrollment": "20", "interventions": "", "nct": "NCT03315585", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Second Military Medical University", "startDate": "2017-04-27", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "The Efficacy and Safety of Composite Steep-pulse Treatment Apparatus Used in Prostate Cancer Focal Therapy", "url": "https://clinicaltrials.gov/study/NCT03315585" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2018-11-30", "conditions": "Advanced Gastric Cancer", "enrollment": "120", "interventions": "", "nct": "NCT03350477", "phase": "PHASE2|PHASE3", "phaseLabel": "Faz 2/3", "regime": null, "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2017-11-30", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Bioinformation Therapy for Gastric Cancer", "url": "https://clinicaltrials.gov/study/NCT03350477" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2018-11-30", "conditions": "Advanced Intestinal Cancer", "enrollment": "120", "interventions": "", "nct": "NCT03350490", "phase": "PHASE2|PHASE3", "phaseLabel": "Faz 2/3", "regime": null, "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2017-11-30", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Bioinformation Therapy for Intestinal Cancer", "url": "https://clinicaltrials.gov/study/NCT03350490" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2021-03-23", "conditions": "Hepatitis B, Chronic", "enrollment": "30", "interventions": "", "nct": "NCT03463369", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Janssen Sciences Ireland UC", "startDate": "2018-04-18", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "A First-In-Human Study to Evaluate Safety, Tolerability, Reactogenicity, and Immunogenicity of JNJ-64300535, a DNA Vaccine, Administered by Electroporation-Mediated Intramuscular Injection, in Participants With Chronic Hepatitis B Who Are on Stable Nucleos(t)Ide Therapy and Virologically Suppressed", "url": "https://clinicaltrials.gov/study/NCT03463369" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2021-05-26", "conditions": "Anal Neoplasm", "enrollment": "23", "interventions": "", "nct": "NCT03499795", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "EVET", "sponsor": "Inovio Pharmaceuticals", "startDate": "2018-05-15", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2", "url": "https://clinicaltrials.gov/study/NCT03499795" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2025-05-09", "conditions": "Urothelial Carcinoma", "enrollment": "35", "interventions": "", "nct": "NCT03502785", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "hayir", "sponsor": "Inovio Pharmaceuticals", "startDate": "2018-05-24", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma", "url": "https://clinicaltrials.gov/study/NCT03502785" }, { "acronym": null, "application": "IRE", "completionDate": "2020-04-30", "conditions": "Prostate Cancer, Prostate Adenocarcinoma", "enrollment": "10", "interventions": "", "nct": "NCT03504995", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "I.M. Sechenov First Moscow State Medical University", "startDate": "2018-04-19", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Efficacy and Safety Assessment of IRE of Localized Prostate Cancer.", "url": "https://clinicaltrials.gov/study/NCT03504995" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2022-07-25", "conditions": "Metastatic Hormone-Sensitive Prostate Cancer", "enrollment": "19", "interventions": "", "nct": "NCT03532217", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Washington University School of Medicine", "startDate": "2018-09-14", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer", "url": "https://clinicaltrials.gov/study/NCT03532217" }, { "acronym": null, "application": "Kalsiyum Elektroporasyonu", "completionDate": "2021-01-01", "conditions": "Colorectal Cancer Stage IV", "enrollment": "6", "interventions": "", "nct": "NCT03542214", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Zealand University Hospital", "startDate": "2018-04-24", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Calcium Electroporation for the Treatment of Colorectal Cancer", "url": "https://clinicaltrials.gov/study/NCT03542214" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2025-06-17", "conditions": "Anal Intraepithelial Neoplasia, High Grade Squamous Intraepithelial Neoplasia, HIV Positivity", "enrollment": "44", "interventions": "", "nct": "NCT03603808", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "EVET", "sponsor": "AIDS Malignancy Consortium", "startDate": "2018-09-21", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions", "url": "https://clinicaltrials.gov/study/NCT03603808" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2021-05-17", "conditions": "HIV-1-infection", "enrollment": "56", "interventions": "", "nct": "NCT03606213", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "EVET", "sponsor": "Steven Deeks", "startDate": "2018-08-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Therapeutic Vaccination in Treated HIV Disease", "url": "https://clinicaltrials.gov/study/NCT03606213" }, { "acronym": null, "application": "IRE", "completionDate": "2021-05-01", "conditions": "Pancreatic Cancer", "enrollment": "30", "interventions": "", "nct": "NCT03614910", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Holy Name Medical Center, Inc.", "startDate": "2018-05-15", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Ablation of Unresectable Locally Advanced Pancreatic Cancer With Irreversible Electroporation (IRE) System", "url": "https://clinicaltrials.gov/study/NCT03614910" }, { "acronym": null, "application": "Kalsiyum Elektroporasyonu", "completionDate": "2019-06-04", "conditions": "Cutaneous Melanoma", "enrollment": "7", "interventions": "PROCEDURE: Calcium Electroporation|PROCEDURE: Bleomycin based electrochemotherapy", "nct": "NCT03628417", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "EVET", "sponsor": "Szeged University", "startDate": "2016-09-20", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "INTERVENTIONAL", "summary": "Electroporation is a method that can facilitate transport of molecules across the cell membrane and into the cell by means of electrical pulses. The method can be used with molecules that normally have difficulty passing the cell membrane such as chemotherapy (electrochemotherapy). Electrochemotherapy (ECT) is used in cancer therapy, where chemotherapy is administered intratumoral or intravenous, then followed by electrical pulses applied directly on the tumor. The chemotherapy accumulates in the cancer cells which results in an increased cytotoxic effect. The most used chemotherapeutic drug used in electrochemotherapy is bleomycin. Electrochemotherapy is a well-documented local treatment form for especially cutaneous tumors. Today, the treatment is used mostly in palliative care in more than 140 centres around Europe. In vitro and in vivo studies have shown that the combination of calci", "title": "Confirmatory Trial in the Evaluation of Ca Electroporation for the Treatment of Cutaneous Metastases", "url": "https://clinicaltrials.gov/study/NCT03628417" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2022-03-31", "conditions": "Locally Advanced Pancreatic Cancer", "enrollment": "32", "interventions": "", "nct": "NCT03648632", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Per Pfeiffer", "startDate": "2018-08-22", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Stereotactic Radiotherapy (SBRT) in Patients With Locally Advanced Pancreatic Cancer (LAPC)", "url": "https://clinicaltrials.gov/study/NCT03648632" }, { "acronym": null, "application": "IRE", "completionDate": "2021-07-30", "conditions": "Locally Advanced Pancreatic Adenocarcinoma", "enrollment": "120", "interventions": "", "nct": "NCT03673137", "phase": "PHASE2|PHASE3", "phaseLabel": "Faz 2/3", "regime": null, "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2019-09-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Phase II/III of Randomized Controlled Clinical Research on IRE Synchronous Chemotherapy for LAPC", "url": "https://clinicaltrials.gov/study/NCT03673137" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2022-09-15", "conditions": "Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion, HSIL", "enrollment": "203", "interventions": "", "nct": "NCT03721978", "phase": "PHASE3", "phaseLabel": "Faz 3", "regime": null, "resultsReported": "EVET", "sponsor": "Inovio Pharmaceuticals", "startDate": "2019-02-28", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)", "url": "https://clinicaltrials.gov/study/NCT03721978" }, { "acronym": null, "application": "IRE", "completionDate": "2021-08-16", "conditions": "Cholangiocarcinoma", "enrollment": "8", "interventions": "", "nct": "NCT03769753", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "EVET", "sponsor": "Memorial Sloan Kettering Cancer Center", "startDate": "2018-12-05", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Trial of IRE in Cholangiocarcinoma", "url": "https://clinicaltrials.gov/study/NCT03769753" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2022-10-03", "conditions": "Metastatic Castration-resistant Prostate Cancer", "enrollment": "43", "interventions": "", "nct": "NCT03835533", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "EVET", "sponsor": "Parker Institute for Cancer Immunotherapy", "startDate": "2019-06-21", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations", "url": "https://clinicaltrials.gov/study/NCT03835533" }, { "acronym": null, "application": "Kalsiyum Elektroporasyonu", "completionDate": "2023-07-27", "conditions": "Cancer", "enrollment": "17", "interventions": "", "nct": "NCT04259658", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Zealand University Hospital", "startDate": "2020-04-20", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Histopathologic Effect of Calcium Electroporation on Cancer in the Skin", "url": "https://clinicaltrials.gov/study/NCT04259658" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2022-12-15", "conditions": "Respiratory Papillomatosis", "enrollment": "32", "interventions": "", "nct": "NCT04398433", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "EVET", "sponsor": "Inovio Pharmaceuticals", "startDate": "2020-10-07", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP)", "url": "https://clinicaltrials.gov/study/NCT04398433" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2022-07-29", "conditions": "Hepatocellular Carcinoma", "enrollment": "44", "interventions": "", "nct": "NCT04420026", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Assistance Publique - Hôpitaux de Paris", "startDate": "2020-07-06", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Study of Automatic Image Fusion of a CT Volume With Ultrasound During Percutaneous Ablation Treatment of Hepatic Tumors", "url": "https://clinicaltrials.gov/study/NCT04420026" }, { "acronym": null, "application": "Kardiyak PFA", "completionDate": "2023-05-09", "conditions": "Atrial Fibrillation", "enrollment": "272", "interventions": "", "nct": "NCT04524364", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "EVET", "sponsor": "Biosense Webster, Inc.", "startDate": "2020-08-23", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "A Study for Treatment of Paroxysmal Atrial Fibrillation (PAF) by Pulsed Field Ablation (PFA) System With Irreversible Electroporation (IRE)", "url": "https://clinicaltrials.gov/study/NCT04524364" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2025-05-22", "conditions": "Melanoma", "enrollment": "17", "interventions": "", "nct": "NCT04526730", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "EVET", "sponsor": "H. Lee Moffitt Cancer Center and Research Institute", "startDate": "2020-12-22", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients", "url": "https://clinicaltrials.gov/study/NCT04526730" }, { "acronym": "CORVax12", "application": "Gen Elektrotransferi", "completionDate": "2022-12-28", "conditions": "SARS-CoV-2", "enrollment": "16", "interventions": "DRUG: CORVax|DRUG: IL-12 plasmid|DEVICE: Cliniporator", "nct": "NCT04627675", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": null, "sponsor": "Providence Health & Services", "startDate": "2020-12-30", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "INTERVENTIONAL", "summary": "This is a Phase 1, open-label study to evaluate the safety profile of CORVax +/- pIL-12, (electroporated SARS-CoV-2 spike (S) protein plasmid DNA vaccine with or without the combination of electroporated IL-12p70 plasmid.", "title": "CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2)", "url": "https://clinicaltrials.gov/study/NCT04627675" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2022-07-20", "conditions": "Oesophageal Cancer, Oesophageal Disease, Gastric Cancer", "enrollment": "30", "interventions": "", "nct": "NCT04649372", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Mirai Medical", "startDate": "2021-01-13", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "EndoVE endosCopic Treatment for Oesophageal and Gastric canceR", "url": "https://clinicaltrials.gov/study/NCT04649372" }, { "acronym": "EPIC", "application": "Belirsiz", "completionDate": "2020-12-21", "conditions": "Tolerance", "enrollment": "24", "interventions": "DEVICE: Electroporation with voltage amplitude of 40 V (corresponding to an electric field strength of 100 V/cm)|DEVICE: Electroporation with voltage amplitude of 60 V (corresponding to an electric field strength of 150 V/cm)", "nct": "NCT04698694", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": null, "sponsor": "University of Milano Bicocca", "startDate": "2020-12-09", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "INTERVENTIONAL", "summary": "This is a single-blind, single-center, randomized, study in healthy subjects in which the volunteer patients will remain blind with respect to the voltage strength received.", "title": "ElectroPoration In a Clinical Setting", "url": "https://clinicaltrials.gov/study/NCT04698694" }, { "acronym": null, "application": "Kalsiyum Elektroporasyonu", "completionDate": "2022-06-13", "conditions": "Esophageal Cancer", "enrollment": "10", "interventions": "", "nct": "NCT04958044", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Michael Patrick Achiam", "startDate": "2021-05-25", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Endoscopic Assisted Calcium Electroporation in Esophageal Cancer", "url": "https://clinicaltrials.gov/study/NCT04958044" }, { "acronym": null, "application": "IRE", "completionDate": "2024-08-14", "conditions": "Prostate Cancer", "enrollment": "121", "interventions": "", "nct": "NCT04972097", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "EVET", "sponsor": "Angiodynamics, Inc.", "startDate": "2022-03-29", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue", "url": "https://clinicaltrials.gov/study/NCT04972097" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2023-11-30", "conditions": "Basal Cell Carcinoma", "enrollment": "9", "interventions": "", "nct": "NCT05077033", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Institute of Oncology Ljubljana", "startDate": "2021-09-28", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Intratumoral phIL12 GET", "url": "https://clinicaltrials.gov/study/NCT05077033" }, { "acronym": null, "application": "IRE", "completionDate": "2023-12-11", "conditions": "Atrial Fibrillation", "enrollment": "362", "interventions": "", "nct": "NCT05293639", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "EVET", "sponsor": "Biosense Webster, Inc.", "startDate": "2022-04-18", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System", "url": "https://clinicaltrials.gov/study/NCT05293639" }, { "acronym": null, "application": "IRE", "completionDate": "2025-05-25", "conditions": "Benign Prostatic Hyperplasia", "enrollment": "118", "interventions": "", "nct": "NCT05306145", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Shanghai East Hospital", "startDate": "2022-06-30", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Comparison of H-FIRE and TURP in Treating Benign Prostatic Hyperplasia", "url": "https://clinicaltrials.gov/study/NCT05306145" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2022-07-08", "conditions": "Benign Prostatic Hyperplasia", "enrollment": "160", "interventions": "", "nct": "NCT05531344", "phase": "PHASE2|PHASE3", "phaseLabel": "Faz 2/3", "regime": null, "resultsReported": "hayir", "sponsor": "REMD Medical Technology", "startDate": "2020-08-20", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Composite Steep-pulseTreatment Device Used in Patients With Benign Prostatic Hyperplasia", "url": "https://clinicaltrials.gov/study/NCT05531344" }, { "acronym": null, "application": "Kardiyak PFA", "completionDate": "2024-12-18", "conditions": "Refractory Paroxysmal Atrial Fibrillation", "enrollment": "142", "interventions": "", "nct": "NCT05552963", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "EVET", "sponsor": "Biosense Webster, Inc.", "startDate": "2022-12-07", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "A Study of Multi-electrode Circular Irreversible Electroporation (IRE) Catheter and Multi-Channel IRE Generator in Paroxysmal Atrial Fibrillation (AF)", "url": "https://clinicaltrials.gov/study/NCT05552963" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2024-10-27", "conditions": "Lung Tumor, Metastatic Cancer", "enrollment": "6", "interventions": "", "nct": "NCT05555342", "phase": "EARLY_PHASE1", "phaseLabel": "Erken Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "University of California, Irvine", "startDate": "2023-01-03", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "A Novel Method for Treating Lung Met w/Combo of Electric Fields & Rad Therapy: A Single-Arm", "url": "https://clinicaltrials.gov/study/NCT05555342" }, { "acronym": null, "application": "IRE", "completionDate": "2025-02-02", "conditions": "Tonsillar Hypertrophy", "enrollment": "24", "interventions": "", "nct": "NCT06187194", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "EVET", "sponsor": "ENTire Medical Ltd.", "startDate": "2024-01-17", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Efficacy and Safety of Irreversible Electroporation for Chronic Symptomatic Tonsillar Hypertrophy Treatment", "url": "https://clinicaltrials.gov/study/NCT06187194" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2025-11-28", "conditions": "Ventricular Tachyarrhythmia, Ventricular Arrythmia, PVC - Premature Ventricular Complex", "enrollment": "34", "interventions": "", "nct": "NCT06203262", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Field Medical", "startDate": "2024-04-12", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Ventricular Catheter Ablation Study (VCAS)", "url": "https://clinicaltrials.gov/study/NCT06203262" }, { "acronym": null, "application": "IRE", "completionDate": "2025-09-15", "conditions": "Pancreatic Cancer, Locally Advanced Pancreatic Cancer", "enrollment": "2", "interventions": "", "nct": "NCT06378047", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "IRE", "resultsReported": "hayir", "sponsor": "H. Lee Moffitt Cancer Center and Research Institute", "startDate": "2024-04-10", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT06378047" }, { "acronym": null, "application": "IRE", "completionDate": "2025-06-27", "conditions": "Inferior Turbinate Hypertrophy, Nasal Obstruction, Turbinate; Hypertrophy Mucous Membrane", "enrollment": "48", "interventions": "", "nct": "NCT06438185", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "ENTire Medical Ltd.", "startDate": "2024-03-07", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Efficacy And Safety of An IRE System For Treatment of Inferior Turbinate Hypertrophy", "url": "https://clinicaltrials.gov/study/NCT06438185" }, { "acronym": null, "application": "ECT", "completionDate": "2022-12-10", "conditions": "Breast Cancer, Breast Cancer Metastatic, Breast Cancer Recurrent", "enrollment": "205", "interventions": "", "nct": "NCT06683404", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "Istituto Oncologico Veneto IRCCS", "startDate": "2016-04-22", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "GISEL:Registry of Breast Cancer Patients Treated With ECT", "url": "https://clinicaltrials.gov/study/NCT06683404" }, { "acronym": null, "application": "ECT", "completionDate": "2023-04-30", "conditions": "Breast Cancer Female", "enrollment": "200", "interventions": "", "nct": "NCT06709937", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS", "startDate": "2020-07-06", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Prospective Multicenter Registry of Patients With Skin Metastases From Breast Cancer Treated With Electrochemotherapy", "url": "https://clinicaltrials.gov/study/NCT06709937" }, { "acronym": null, "application": "IRE", "completionDate": "2025-10-22", "conditions": "Tonsillar Hypertrophy, Upper Airway Obstruction", "enrollment": "31", "interventions": "", "nct": "NCT06960239", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "ENTire Medical Ltd.", "startDate": "2024-11-14", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Safety and Efficacy of the Irreversible Electroporation (IRE) System for Adenotonsillar Hypertrophy in Children", "url": "https://clinicaltrials.gov/study/NCT06960239" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2025-11-20", "conditions": "Ventilation, Ablation Techniques", "enrollment": "41", "interventions": "", "nct": "NCT07291271", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", "startDate": "2024-08-20", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Use of Flow-Controlled Ventilation During CT-Guided Percutaneous Liver Tumor Ablation", "url": "https://clinicaltrials.gov/study/NCT07291271" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2025-12-31", "conditions": "Peripheral Pulmonary Nodules, Ablation Techniques", "enrollment": "25", "interventions": "", "nct": "NCT07642986", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Jisong Zhang", "startDate": "2024-05-01", "status": "COMPLETED", "statusKey": "completed", "statusLabel": "Tamamlandı", "studyType": "", "summary": null, "title": "Diagnosis and Treatment of Lung Lesions", "url": "https://clinicaltrials.gov/study/NCT07642986" }, { "acronym": null, "application": "ECT", "completionDate": null, "conditions": "Melanoma (Skin)", "enrollment": null, "interventions": "", "nct": "NCT00006035", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "ECT", "resultsReported": "hayir", "sponsor": "H. Lee Moffitt Cancer Center and Research Institute", "startDate": "2000-06", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma", "url": "https://clinicaltrials.gov/study/NCT00006035" }, { "acronym": null, "application": "IRE", "completionDate": null, "conditions": "Metastatic Liver Cancer, Cholangiocarcinoma, Neoplasm Metastasis", "enrollment": "5", "interventions": "", "nct": "NCT01442324", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Azienda Ospedaliera di Padova", "startDate": "2011-02", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma", "url": "https://clinicaltrials.gov/study/NCT01442324" }, { "acronym": null, "application": "IRE", "completionDate": null, "conditions": "Prostate Cancer", "enrollment": "20", "interventions": "", "nct": "NCT01726894", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "University College London Hospitals", "startDate": "2013-10", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Focal Therapy for Localised Prostate Cancer Using Irreversible Electroporation", "url": "https://clinicaltrials.gov/study/NCT01726894" }, { "acronym": null, "application": "IRE", "completionDate": "2025-01", "conditions": "Prostate Cancer", "enrollment": "106", "interventions": "", "nct": "NCT01835977", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Clinical Research Office of the Endourological Society", "startDate": "2015-06", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer", "url": "https://clinicaltrials.gov/study/NCT01835977" }, { "acronym": null, "application": "IRE", "completionDate": "2016-01", "conditions": "Kidney Tumor, Renal Cell Cancer", "enrollment": "20", "interventions": "", "nct": "NCT01967407", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "hayir", "sponsor": "University of Magdeburg", "startDate": "2013-10", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "IReversible Electroporation of Kidney Tumors Before Partial Nephrectomy.", "url": "https://clinicaltrials.gov/study/NCT01967407" }, { "acronym": null, "application": "IRE", "completionDate": "2024-05", "conditions": "Prostate Cancer", "enrollment": "6", "interventions": "", "nct": "NCT01972867", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Angiodynamics, Inc.", "startDate": "2021-05-13", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients", "url": "https://clinicaltrials.gov/study/NCT01972867" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2018-01", "conditions": "Cervical Intraepithelial Neoplasia 3", "enrollment": "9", "interventions": "", "nct": "NCT02100085", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "Genexine, Inc.", "startDate": "2014-02", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation", "url": "https://clinicaltrials.gov/study/NCT02100085" }, { "acronym": null, "application": "IRE", "completionDate": "2025-04", "conditions": "Prostate Cancer", "enrollment": "361", "interventions": "", "nct": "NCT02255890", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Clinical Research Office of the Endourological Society", "startDate": "2014-11", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device", "url": "https://clinicaltrials.gov/study/NCT02255890" }, { "acronym": null, "application": "IRE", "completionDate": "2016-12", "conditions": "Kidney Cancer", "enrollment": "10", "interventions": "", "nct": "NCT02298608", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "hayir", "sponsor": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", "startDate": "2014-01", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Efficacy and Safety of IRE for RMs", "url": "https://clinicaltrials.gov/study/NCT02298608" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2018-12", "conditions": "B-Cell Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma", "enrollment": "18", "interventions": "", "nct": "NCT02315118", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "hayir", "sponsor": "National University Hospital, Singapore", "startDate": "2014-12", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies", "url": "https://clinicaltrials.gov/study/NCT02315118" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2018-11", "conditions": "Cervical Intraepithelial Neoplasia 3", "enrollment": "67", "interventions": "", "nct": "NCT02411019", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "Genexine, Inc.", "startDate": "2015-03", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation", "url": "https://clinicaltrials.gov/study/NCT02411019" }, { "acronym": null, "application": "ECT", "completionDate": "2019-09", "conditions": "Head Neck Cancer", "enrollment": "25", "interventions": "PROCEDURE: Electrochemotherapy|DEVICE: Cliniporator|DRUG: Bleomycin", "nct": "NCT02549742", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Rigshospitalet, Denmark", "startDate": "2014-02", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "INTERVENTIONAL", "summary": "A phase II clinical trial testing electrochemotherapy on mucosal recurrent head and neck cancer. Twenty-five patients will be treated. Primary outcome is tumour response on imaging. Secondary outcomes are response from tissue samples, VAS score, Quality of life evaluation and side effects to treatment.", "title": "Electrochemotherapy on Head and Neck Cancer", "url": "https://clinicaltrials.gov/study/NCT02549742" }, { "acronym": null, "application": "IRE", "completionDate": "2017-01", "conditions": "Neoplasms, Carcinoma", "enrollment": "20", "interventions": "", "nct": "NCT02567734", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Yueyong Xiao", "startDate": "2015-10", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Clinical Trials of CT-guided Percutaneous Irreversible Electroporation（IRE）in the Treatment of Patients With Locally Advanced Tumors", "url": "https://clinicaltrials.gov/study/NCT02567734" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2018-08", "conditions": "Cervical Intraepithelial Neoplasia", "enrollment": "134", "interventions": "", "nct": "NCT02596243", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Genexine, Inc.", "startDate": "2015-08", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E)", "url": "https://clinicaltrials.gov/study/NCT02596243" }, { "acronym": null, "application": "IRE", "completionDate": "2018-06", "conditions": "Refractory Neoplasms", "enrollment": "60", "interventions": "", "nct": "NCT02822066", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": "IRE", "resultsReported": "hayir", "sponsor": "First Affiliated Hospital of Zhejiang University", "startDate": "2016-04", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Effectivity and Safety of Irreversible Electroporation for Refractory Neoplasms in Liver and Pancreas", "url": "https://clinicaltrials.gov/study/NCT02822066" }, { "acronym": null, "application": "IRE", "completionDate": "2019-07", "conditions": "Kidney Cancer", "enrollment": "20", "interventions": "", "nct": "NCT02828709", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Dr. Prof. M.P. Laguna Pes", "startDate": "2016-07", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Safety and Feasibility of IRE for SRMs", "url": "https://clinicaltrials.gov/study/NCT02828709" }, { "acronym": null, "application": "Elektroskleroterapi", "completionDate": "2018-03", "conditions": "Capillary Malformations|Vascular Malformations", "enrollment": "20", "interventions": "OTHER: Electrosclerotherapy|DRUG: Intralesional bleomycin injection", "nct": "NCT02883023", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Sophie Horbach", "startDate": "2016-11", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "INTERVENTIONAL", "summary": "Capillary malformations (port-wine stains) consist of abnormally developed capillary blood vessels in the skin. To date, laser therapy is the only widely accepted treatment modality for capillary malformations, but this therapy has a suboptimal effect in approximately 50-60% of patients. Intralesional bleomycin injections (sclerotherapy) are a common effective treatment option for vascular malformations with blood vessels with larger diameters. However, bleomycin cannot be injected adequately in the small sized vessels of capillary malformations. The use of an electric field over the tissue (electroporation) may solve this problem: it increases cell membrane permeability and therefore promotes localized delivery of drugs, within (endothelial) cells. Electroporation in combination with bleomycin sclerotherapy ('electrosclerotherapy') may therefore offer new therapeutic options for capilla", "title": "Electrosclerotherapy for Capillary Malformations", "url": "https://clinicaltrials.gov/study/NCT02883023" }, { "acronym": null, "application": "IRE", "completionDate": "2019-08", "conditions": "Locally Advanced Pancreatic Cancer", "enrollment": "100", "interventions": "", "nct": "NCT02898649", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Yonsei University", "startDate": "2015-12", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Safety and Efficacy of Irreversible Electroporation for Locally Advanced Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT02898649" }, { "acronym": "nECT", "application": "ECT", "completionDate": "2019-09", "conditions": "Locally Advanced Rectal Cancer|Electrochemotherapy|Neoadjuvant Therapy|Down Staging", "enrollment": "40", "interventions": "DRUG: Electrochemotherapy with bleomycin|DEVICE: EndoVE", "nct": "NCT03040180", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Zealand University Hospital", "startDate": "2017-01", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "INTERVENTIONAL", "summary": "The purpose of this study is to evaluate the efficacy and safety of neoadjuvant electrochemotherapy on locally advanced rectal cancer (UICC II-III) in an intended curative clinical setting, using an endoscopic electroporation device (EndoVE).", "title": "Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer", "url": "https://clinicaltrials.gov/study/NCT03040180" }, { "acronym": null, "application": "Kalsiyum Elektroporasyonu", "completionDate": "2019-02", "conditions": "Head Neck Cancer", "enrollment": "6", "interventions": "DRUG: Calcium chloride|DEVICE: Electroporation", "nct": "NCT03051269", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Rigshospitalet, Denmark", "startDate": "2016-05", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "INTERVENTIONAL", "summary": "In a phase I protocol to primarily investigate the safety of using calcium combined with electroporation on recurrent head and neck cancers. Secondly, to evaluate tumour response on PET/MRI (positron emission tomography/magnetic resonance imaging), clinical evaluation, biopsies. Thirdly, to evaluate the effect of calcium electroporation compared to electrochemotherapy as well as the patients life-of-quality through questionnaires, EORTC QLQ C-30 and H\\&N35 (european organisation for research and treatment of cancer).", "title": "Calcium Electroporation for Head and Neck Cancer", "url": "https://clinicaltrials.gov/study/NCT03051269" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2021-07", "conditions": "Myelodysplastic Syndromes, Acute Myeloid Leukemia", "enrollment": "5", "interventions": "", "nct": "NCT03083054", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "hayir", "sponsor": "University of Campinas, Brazil", "startDate": "2016-08", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Cellular Immunotherapy for Patients With High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia", "url": "https://clinicaltrials.gov/study/NCT03083054" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2024-07-31", "conditions": "Stage III/IV Melanoma", "enrollment": "143", "interventions": "", "nct": "NCT03132675", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "OncoSec Medical Incorporated", "startDate": "2017-10-03", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Either Pembrolizumab or Nivolumab Treatment", "url": "https://clinicaltrials.gov/study/NCT03132675" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2022-05", "conditions": "B Cell Leukemia, B Cell Lymphoma", "enrollment": "80", "interventions": "", "nct": "NCT03166878", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "hayir", "sponsor": "Chinese PLA General Hospital", "startDate": "2017-06", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "A Study Evaluating UCART019 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma", "url": "https://clinicaltrials.gov/study/NCT03166878" }, { "acronym": null, "application": "IRE", "completionDate": "2019-08-01", "conditions": "Oncology", "enrollment": "25", "interventions": "", "nct": "NCT03169439", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Assiut University", "startDate": "2017-07-01", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Irreversible Electroporation for Treatment of Solid Abdominal Tumors", "url": "https://clinicaltrials.gov/study/NCT03169439" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2018-10", "conditions": "Cervical Intraepithelial Neoplasia 3", "enrollment": "50", "interventions": "", "nct": "NCT03206138", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Seoul St. Mary's Hospital", "startDate": "2017-05-30", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.", "url": "https://clinicaltrials.gov/study/NCT03206138" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2023-12-30", "conditions": "Solid Tumor Including Thyroid, Bone, Liver, Pancreas", "enrollment": "500", "interventions": "", "nct": "NCT03362749", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "National Taiwan University Hospital", "startDate": "2017-09-01", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Eastern Ablation Registry for Solid Tumor (EAST)", "url": "https://clinicaltrials.gov/study/NCT03362749" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2019-12", "conditions": "Solid Tumours", "enrollment": "30", "interventions": "", "nct": "NCT03415100", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "The Third Affiliated Hospital of Guangzhou Medical University", "startDate": "2018-01-02", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Pilot Study of NKG2D-Ligand Targeted CAR-NK Cells in Patients With Metastatic Solid Tumours", "url": "https://clinicaltrials.gov/study/NCT03415100" }, { "acronym": null, "application": "IRE", "completionDate": "2019-05-30", "conditions": "Lower Urinary Tract Symptoms", "enrollment": "100", "interventions": "", "nct": "NCT03448510", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Changhai Hospital", "startDate": "2018-04-01", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Irreversible Electroporation Versus Standard Medication for Benign Prostatic Obstruction", "url": "https://clinicaltrials.gov/study/NCT03448510" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2024-09", "conditions": "Triple Negative Breast Cancer", "enrollment": "65", "interventions": "", "nct": "NCT03567720", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "OncoSec Medical Incorporated", "startDate": "2018-10-11", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC", "url": "https://clinicaltrials.gov/study/NCT03567720" }, { "acronym": null, "application": "Kalsiyum Elektroporasyonu", "completionDate": "2020-09-01", "conditions": "Colorectal Cancer", "enrollment": "24", "interventions": "", "nct": "NCT03694080", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Zealand University Hospital", "startDate": "2018-11-01", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Calcium Electroporation for Early Colorectal Cancer", "url": "https://clinicaltrials.gov/study/NCT03694080" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2020-01-18", "conditions": "Prostate Cancer", "enrollment": "119", "interventions": "", "nct": "NCT03838432", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Second Military Medical University", "startDate": "2018-05-02", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "The Composite Steep-pulse Treatment Apparatus Used in Prostate Cancer Ablation Therapy", "url": "https://clinicaltrials.gov/study/NCT03838432" }, { "acronym": null, "application": "Belirsiz", "completionDate": null, "conditions": "Solid Tumor, Adult", "enrollment": null, "interventions": "", "nct": "NCT03914872", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "Washington University School of Medicine", "startDate": null, "status": "NO_LONGER_AVAILABLE", "statusKey": "unknown", "statusLabel": "Artık Sunulmuyor", "studyType": "", "summary": null, "title": "Expanded Access Neoantigen Vaccine in Solid Tumors", "url": "https://clinicaltrials.gov/study/NCT03914872" }, { "acronym": null, "application": "IRE", "completionDate": "2020-06-06", "conditions": "Prostate Cancer", "enrollment": "1000", "interventions": "", "nct": "NCT03982706", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Rabin Medical Center", "startDate": "2015-10-28", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Examination of Focal Therapies- MRI-Fusion, HIFU, NanoKnife and Cryotherapy", "url": "https://clinicaltrials.gov/study/NCT03982706" }, { "acronym": null, "application": "IRE", "completionDate": "2024-05", "conditions": "Unresectable Pancreatic Cancer", "enrollment": "30", "interventions": "", "nct": "NCT04093141", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery", "startDate": "2019-05-01", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Chemotherapy Followed by Irreversible Electroporation in Patients With Unresectable Locally Advanced Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT04093141" }, { "acronym": null, "application": "ECT", "completionDate": "2021-07-01", "conditions": "Gastric Cancer", "enrollment": "8", "interventions": "DRUG: Bleomycin", "nct": "NCT04139070", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Zealand University Hospital", "startDate": "2020-06-15", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "INTERVENTIONAL", "summary": "This is an explorative, phase I clinical trial. The aim of this study is to establish the safety and efficacy of electrochemotherapy for non-curable gastric cancer.", "title": "Electrochemotherapy for Non-curable Gastric Cancer", "url": "https://clinicaltrials.gov/study/NCT04139070" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2021-03-25", "conditions": "Hepatocellular Carcinoma", "enrollment": "1000", "interventions": "", "nct": "NCT04163627", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "University Hospital, Montpellier", "startDate": "2019-11-30", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Changing Trends in HCC Procedures", "url": "https://clinicaltrials.gov/study/NCT04163627" }, { "acronym": null, "application": "IRE", "completionDate": "2021-12-01", "conditions": "Prostate Cancer, Prostate Adenocarcinoma", "enrollment": "12", "interventions": "", "nct": "NCT04192890", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "I.M. Sechenov First Moscow State Medical University", "startDate": "2020-01-27", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Efficacy and Safety Assessment of IRE of Localized Prostate Cancer", "url": "https://clinicaltrials.gov/study/NCT04192890" }, { "acronym": null, "application": "Kalsiyum Elektroporasyonu", "completionDate": "2023-08-01", "conditions": "Cancer", "enrollment": "19", "interventions": "", "nct": "NCT04225767", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Zealand University Hospital", "startDate": "2020-02-18", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Calcium Electroporation as a Treatment for Cutaneous and Subcutaneous Malignant Tumours", "url": "https://clinicaltrials.gov/study/NCT04225767" }, { "acronym": null, "application": "IRE", "completionDate": "2026-09-01", "conditions": "Prostate Cancer, Treatment", "enrollment": "216", "interventions": "", "nct": "NCT04278261", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Shanghai East Hospital", "startDate": "2022-07-01", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "Comparison H-FIRE and Laparoscopic RP in Treating Men With Localized Prostate Cancer", "url": "https://clinicaltrials.gov/study/NCT04278261" }, { "acronym": null, "application": "IRE", "completionDate": "2020-12-01", "conditions": "Pancreatic Cancer, Locally Advanced Pancreatic Caner", "enrollment": "240", "interventions": "", "nct": "NCT04310553", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "RenJi Hospital", "startDate": "2017-12-01", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "An Open-label, Multicenter, Prospective Study of Irreversible Electroporation (Nano Knife) Combined With Radiotherapy and Chemotherapy in Patients With Locally Advanced Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT04310553" }, { "acronym": null, "application": "Kalsiyum Elektroporasyonu", "completionDate": "2021-09-01", "conditions": "Barretts Esophagus With High Grade Dysplasia", "enrollment": "6", "interventions": "", "nct": "NCT04605419", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Michael Patrick Achiam", "startDate": "2020-10-07", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Calcium Electroporation in Patients With Cell Changes in the Esophagus", "url": "https://clinicaltrials.gov/study/NCT04605419" }, { "acronym": null, "application": "IRE", "completionDate": "2023-06-01", "conditions": "Pancreatic Cancer, Metastatic Pancreatic Cancer", "enrollment": "18", "interventions": "", "nct": "NCT04612530", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Amsterdam UMC, location VUmc", "startDate": "2020-09-01", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT04612530" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2024-10", "conditions": "Prostate Cancer", "enrollment": "260", "interventions": "", "nct": "NCT04773821", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Assistance Publique - Hôpitaux de Paris", "startDate": "2021-06-02", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Performance of Prostate MRI and Following Biopsy to Detect Prostate Cancer Recurrence After Focal Therapy", "url": "https://clinicaltrials.gov/study/NCT04773821" }, { "acronym": null, "application": "ECT", "completionDate": "2023-12-01", "conditions": "Colorectal Cancer", "enrollment": "24", "interventions": "PROCEDURE: Electrochemotheraoy|PROCEDURE: Electroporation with saline (placebo)", "nct": "NCT04816045", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Zealand University Hospital", "startDate": "2021-05-01", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "INTERVENTIONAL", "summary": "This is a randomized controlled trial investigating efficacy of electrochemotherapy for early colorectal cancer", "title": "Neoadjuvant Electrochemotherapy for Colorectal Cancer - a Randomized Controlled Trial", "url": "https://clinicaltrials.gov/study/NCT04816045" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2021-05-01", "conditions": "Focal Treatment for Prostate Cancer", "enrollment": "10", "interventions": "", "nct": "NCT04831905", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Jules Bordet Institute", "startDate": "2021-03-01", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Micro-wave Ablation Under Organ-based Tracking in Patients With Prostate Cancer - FOSTINE", "url": "https://clinicaltrials.gov/study/NCT04831905" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2025-12", "conditions": "Pancreas Cancer, Metastatic", "enrollment": "8", "interventions": "", "nct": "NCT04835402", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery", "startDate": "2021-05-26", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Electroporation Potentiated Immunotherapy in Cancer", "url": "https://clinicaltrials.gov/study/NCT04835402" }, { "acronym": null, "application": "Kalsiyum Elektroporasyonu", "completionDate": "2022-02-22", "conditions": "Basal Cell Carcinoma", "enrollment": "25", "interventions": "", "nct": "NCT05046262", "phase": "PHASE3", "phaseLabel": "Faz 3", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Bispebjerg Hospital", "startDate": "2020-01-08", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study", "url": "https://clinicaltrials.gov/study/NCT05046262" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2024-12", "conditions": "Pancreas Cancer", "enrollment": "30", "interventions": "", "nct": "NCT05170802", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "Methodist Health System", "startDate": "2017-12-20", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Pancreatic Cancer & Surgical Resection", "url": "https://clinicaltrials.gov/study/NCT05170802" }, { "acronym": null, "application": "IRE", "completionDate": "2024-09", "conditions": "Prostate Cancer", "enrollment": "10", "interventions": "", "nct": "NCT05512663", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Jewish General Hospital", "startDate": "2022-09", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Safety and Efficacy Evaluation of Transperineal Irreversible Electroporation (IRE) of Anterior Prostate Cancer", "url": "https://clinicaltrials.gov/study/NCT05512663" }, { "acronym": null, "application": "IRE", "completionDate": "2025-03-10", "conditions": "Chronic Bronchitis", "enrollment": "15", "interventions": "", "nct": "NCT05771129", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Jiayuan Sun", "startDate": "2023-03-10", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Feasibility Study of the Pulsed Electric Field Ablation System in Treating Chronic Bronchitis", "url": "https://clinicaltrials.gov/study/NCT05771129" }, { "acronym": null, "application": "IRE", "completionDate": "2028-12", "conditions": "Liver Metastasis Colon Cancer", "enrollment": "12", "interventions": "", "nct": "NCT06047015", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": "IRE", "resultsReported": "hayir", "sponsor": "University of Saskatchewan", "startDate": "2025-07", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "Irreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal Cancer", "url": "https://clinicaltrials.gov/study/NCT06047015" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2025-06", "conditions": "Hepatocellular Carcinoma", "enrollment": "9", "interventions": "", "nct": "NCT06088459", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Newish Technology (Beijing) Co., Ltd.", "startDate": "2023-11", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "NWRD06 DNA Plasmid for HCC After Radical Resection", "url": "https://clinicaltrials.gov/study/NCT06088459" }, { "acronym": null, "application": "IRE", "completionDate": "2025-05-23", "conditions": "Liver Cancer", "enrollment": "50", "interventions": "", "nct": "NCT06289712", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "Assistance Publique - Hôpitaux de Paris", "startDate": "2023-11-23", "status": "UNKNOWN", "statusKey": "unknown", "statusLabel": "Durum Bilinmiyor", "studyType": "", "summary": null, "title": "Evaluation of the Ablation of Hepatic Lesions by Electroporation", "url": "https://clinicaltrials.gov/study/NCT06289712" }, { "acronym": null, "application": "IRE", "completionDate": "2025-06-30", "conditions": "Pancreatic Cancer", "enrollment": "55", "interventions": "", "nct": "NCT06677762", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Ruijin Hospital", "startDate": "2024-11-10", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "Irreversible Electroporation Ablation Combined With Anti-PD(L)1 Therapy for Locally Advanced Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT06677762" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2032-02", "conditions": "Prostate, Prostate Cancer", "enrollment": "1000", "interventions": "", "nct": "NCT06772116", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "Institut Mutualiste Montsouris", "startDate": "2025-02", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "Focal Therapy in Localized Prostate Cancer: a Prospective Registry", "url": "https://clinicaltrials.gov/study/NCT06772116" }, { "acronym": null, "application": "Kardiyak PFA", "completionDate": "2025-12-01", "conditions": "Atrial Fibrillation (AF)", "enrollment": "60", "interventions": "", "nct": "NCT06850064", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Shanghai Chest Hospital", "startDate": "2025-02-24", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "Efficacy and Safety of Pulsed Field Ablation in Refractory Mitral Isthmus-dependent Atrial Flutter: Pulsed Field Ablation Vs. Radiofrequency Ablation: a Preliminary Randomized Controlled Study", "url": "https://clinicaltrials.gov/study/NCT06850064" }, { "acronym": null, "application": "IRE", "completionDate": "2027-06-30", "conditions": "Prostate Cancer", "enrollment": "10", "interventions": "", "nct": "NCT06886321", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Chinese University of Hong Kong", "startDate": "2025-06-30", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "Prostate Irreversible Electroporation Study", "url": "https://clinicaltrials.gov/study/NCT06886321" }, { "acronym": null, "application": "IRE", "completionDate": "2028-04-28", "conditions": "Pancreatic Cancer, Adult", "enrollment": "48", "interventions": "", "nct": "NCT06938503", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Tianjin Medical University Cancer Institute and Hospital", "startDate": "2025-04-21", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT06938503" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2027-07-31", "conditions": "Liver Tumors", "enrollment": "20", "interventions": "", "nct": "NCT07063771", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "National Taiwan University Hospital", "startDate": "2025-08-01", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "Safety and Clinical Efficacy of Histotripsy for Liver Cancers Adjacent to Major Intrahepatic Vessels", "url": "https://clinicaltrials.gov/study/NCT07063771" }, { "acronym": null, "application": "IRE", "completionDate": "2029-02", "conditions": "Colorectal Adenocarcinoma Metastatic in the Liver, Liver Ablation, Liver Cancer, Adult", "enrollment": "50", "interventions": "", "nct": "NCT07191548", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Angiodynamics, Inc.", "startDate": "2026-02", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "International Study on Treatment of Patients With Metastatic Colorectal Liver Lesions Patients With IRE", "url": "https://clinicaltrials.gov/study/NCT07191548" }, { "acronym": null, "application": "IRE", "completionDate": "2029-02", "conditions": "Hepatocellular Carcinoma (HCC), Liver Ablation, Liver Cancer, Adult", "enrollment": "50", "interventions": "", "nct": "NCT07192731", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Angiodynamics, Inc.", "startDate": "2026-02", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "International Study on Treatment of Liver (HCC) Patients With IRE", "url": "https://clinicaltrials.gov/study/NCT07192731" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2031-10", "conditions": "Atrial Fibrillation, Heart Failure With Preserved Ejection Fraction", "enrollment": "900", "interventions": "", "nct": "NCT07254455", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Tulane University", "startDate": "2026-07", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "CASTLE-HFpEF (Catheter Ablation for Atrial Fibrillation Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction)", "url": "https://clinicaltrials.gov/study/NCT07254455" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2032-08-30", "conditions": "Diabete Mellitus, T2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin)", "enrollment": "40", "interventions": "", "nct": "NCT07376486", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Chinese University of Hong Kong", "startDate": "2026-09-01", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "Duodenal pulsENDO as an Early Treatment for Type 2 DM", "url": "https://clinicaltrials.gov/study/NCT07376486" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2033-08-30", "conditions": "T2DM (Type 2 Diabetes Mellitus), MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Syndrome (MetS)", "enrollment": "40", "interventions": "", "nct": "NCT07390422", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Chinese University of Hong Kong", "startDate": "2026-09-01", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "Duodenal pulsENDO for Suboptimally Controlled Type II Diabetes Mellitus and Steatotic Liver Disease", "url": "https://clinicaltrials.gov/study/NCT07390422" }, { "acronym": null, "application": "Kalsiyum Elektroporasyonu", "completionDate": "2030-04", "conditions": "Bladder Tumors, Bladder Tumor, Urothelial Carcinoma (UC)", "enrollment": "20", "interventions": "", "nct": "NCT07555769", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Juan Luis Vásquez", "startDate": "2026-06", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "Calcium Electroporation for Urinary Bladder Tumors: A First-in-Human Feasibility, Safety, and Early Response Trial", "url": "https://clinicaltrials.gov/study/NCT07555769" }, { "acronym": null, "application": "IRE", "completionDate": "2029-05-05", "conditions": "BPH", "enrollment": "288", "interventions": "", "nct": "NCT07572097", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Shanghai East Hospital", "startDate": "2026-05-05", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "High-Frequency Irreversible Electroporation vs Standard of Care for Benign Prostatic Hyperplasia", "url": "https://clinicaltrials.gov/study/NCT07572097" }, { "acronym": null, "application": "Kardiyak PFA", "completionDate": "2026-06-30", "conditions": "Atrial Fibrillation (AF)", "enrollment": "30", "interventions": "", "nct": "NCT07577544", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "Shanghai Zhongshan Hospital", "startDate": "2026-05-15", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "Pulsed Field Ablation in the Coronary Sinus: Feasibility and Safety of a Novel Approach for Mitral Isthmus Block", "url": "https://clinicaltrials.gov/study/NCT07577544" }, { "acronym": null, "application": "Elektroskleroterapi", "completionDate": "2032-06-30", "conditions": "Vascular Malformations", "enrollment": "140", "interventions": "", "nct": "NCT07579962", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Institute of Oncology Ljubljana", "startDate": "2026-06-30", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "Treatment of Low-flow Vascular Malformations With Bleomycin Electrosclerotherapy (BEST)", "url": "https://clinicaltrials.gov/study/NCT07579962" }, { "acronym": null, "application": "IRE", "completionDate": "2031-06", "conditions": "Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)", "enrollment": "40", "interventions": "", "nct": "NCT07640776", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Angiodynamics, Inc.", "startDate": "2026-09", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)", "url": "https://clinicaltrials.gov/study/NCT07640776" }, { "acronym": null, "application": "Kalsiyum Elektroporasyonu", "completionDate": "2031-12", "conditions": "Calcium Electroporation for Hemostasis in Gastric Neoplasms", "enrollment": "28", "interventions": "", "nct": "NCT07647731", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Hospital del Rio Hortega", "startDate": "2026-06", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "Endoscopic Calcium Electroporation in Gastric Tumors", "url": "https://clinicaltrials.gov/study/NCT07647731" }, { "acronym": null, "application": "Kardiyak PFA", "completionDate": "2028-09-01", "conditions": "Atrial Fibrillation (AF)", "enrollment": "60", "interventions": "", "nct": "NCT07721948", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "University Medical Centre Ljubljana", "startDate": "2026-09-01", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "Assessment of Catheter Tissue Contact in PFA", "url": "https://clinicaltrials.gov/study/NCT07721948" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2032-06", "conditions": "HCC", "enrollment": "90", "interventions": "", "nct": "NCT07722741", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Geneos Therapeutics", "startDate": "2026-09", "status": "NOT_YET_RECRUITING", "statusKey": "unknown", "statusLabel": "Henüz Başlamadı", "studyType": "", "summary": null, "title": "Personalized Neoantigen Vaccine Plus IL-12 (INO-9012) Versus Active Surveillance in Subjects With High-Risk HCC", "url": "https://clinicaltrials.gov/study/NCT07722741" }, { "acronym": null, "application": "ECT", "completionDate": "2007-06-01", "conditions": "Head and Neck Cancer", "enrollment": "130", "interventions": "", "nct": "NCT00198315", "phase": "PHASE3", "phaseLabel": "Faz 3", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Inovio Pharmaceuticals", "startDate": "2004-06", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma", "url": "https://clinicaltrials.gov/study/NCT00198315" }, { "acronym": null, "application": "ECT", "completionDate": "2007-06", "conditions": "Head Neck Cancer", "enrollment": "84", "interventions": "", "nct": "NCT00198328", "phase": "PHASE3", "phaseLabel": "Faz 3", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Inovio Pharmaceuticals", "startDate": "2004-11", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma", "url": "https://clinicaltrials.gov/study/NCT00198328" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2019-05-28", "conditions": "Carcinoma, Advanced Metastatic", "enrollment": "46", "interventions": "", "nct": "NCT00684294", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Mary Crowley Medical Research Center", "startDate": "2008-05-27", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer", "url": "https://clinicaltrials.gov/study/NCT00684294" }, { "acronym": null, "application": "ECT", "completionDate": "2010-12", "conditions": "Breast Cancer", "enrollment": "17", "interventions": "PROCEDURE: Electrochemotherapy", "nct": "NCT00744653", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "ECT", "resultsReported": "EVET", "sponsor": "Copenhagen University Hospital at Herlev", "startDate": "2008-10", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "INTERVENTIONAL", "summary": "By applying short electric pulses to cells, the cell membranes can become permeabilised (electroporation). This can be used augment the effect of chemotherapy, by providing direct access to the cell cytosol. For the drug bleomycin, the enhancement of effect is several hundred fold, enabling once-only treatment. We wish to offer electrochemotherapy to breast cancer patients suffering from chest wall recurrences that are ulcerated or painful and where other treatments have failed.", "title": "Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects.", "url": "https://clinicaltrials.gov/study/NCT00744653" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2013-01", "conditions": "Melanoma", "enrollment": "5", "interventions": "", "nct": "NCT01045915", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Valerio Therapeutics", "startDate": "2010-07", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma", "url": "https://clinicaltrials.gov/study/NCT01045915" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2017-07-07", "conditions": "Malignant Melanoma", "enrollment": "35", "interventions": "", "nct": "NCT01138410", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "hayir", "sponsor": "Scancell Ltd", "startDate": "2010-05", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Study of a DNA Immunotherapy to Treat Melanoma", "url": "https://clinicaltrials.gov/study/NCT01138410" }, { "acronym": null, "application": "ECT", "completionDate": "2013-07", "conditions": "Brain Metastases|CNS Metastases", "enrollment": "1", "interventions": "DEVICE: The Electroporation System|DRUG: Bleomycin", "nct": "NCT01322100", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Copenhagen University Hospital at Herlev", "startDate": "2011-04", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "INTERVENTIONAL", "summary": "Because electrochemotherapy is a quick and effective treatment for cutaneous metastases, a novel electrode device has been developed for treatment in soft tissue such as the brain. Up to 18 patients will be treated in this phase I dose-escalating study of electrochemotherapy for brain metastases. Primary endpoint of the clinical trial is safety and secondary endpoint is efficacy. One brain metastasis is treated once-only with the electrode device guided stereotactically through a burr hole using CT monitoring. The patient will be fully anesthetized during the treatment procedure. Patients are followed up for 6 months with regard to neurological function, Barthel Index, steroid use and adverse effects registration (CTCAE). Tumor response will be evaluated by Magnetic Resonance imaging (MRI).", "title": "Electrochemotherapy as a Palliative Treatment for Brain Metastases", "url": "https://clinicaltrials.gov/study/NCT01322100" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2015-10", "conditions": "Head and Neck Cancer", "enrollment": "2", "interventions": "", "nct": "NCT01493154", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "startDate": "2012-04", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients", "url": "https://clinicaltrials.gov/study/NCT01493154" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2014-06-03", "conditions": "Cutaneous T Cell Lymphomas (CTCL), Mycosis Fungoides (MF)", "enrollment": "2", "interventions": "", "nct": "NCT01579318", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "EVET", "sponsor": "OncoSec Medical Incorporated", "startDate": "2012-06-08", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma", "url": "https://clinicaltrials.gov/study/NCT01579318" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2015-05", "conditions": "Metastatic Malignant Neoplasm", "enrollment": "7", "interventions": "", "nct": "NCT01664273", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Copenhagen University Hospital at Herlev", "startDate": "2012-07", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Gene Electrotransfer to Muscle With Plasmid AMEP in Patients With Disseminated Cancer", "url": "https://clinicaltrials.gov/study/NCT01664273" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2016-11-14", "conditions": "Head and Neck Squamous Cell Carcinoma", "enrollment": "4", "interventions": "", "nct": "NCT02345330", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "EVET", "sponsor": "OncoSec Medical Incorporated", "startDate": "2015-05-21", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Trial of pIL-12 Electroporation in Squamous Cell Carcinoma of the Head and Neck (IL12HNSCC)", "url": "https://clinicaltrials.gov/study/NCT02345330" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2018-02-13", "conditions": "Metastatic Colorectal Cancer", "enrollment": "9", "interventions": "", "nct": "NCT02611661", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "hayir", "sponsor": "Washington University School of Medicine", "startDate": "2016-01-19", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Local Ablative Strategies After Endovascular Radioembolization", "url": "https://clinicaltrials.gov/study/NCT02611661" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2021-02-23", "conditions": "Prostatic Neoplasms", "enrollment": "91", "interventions": "", "nct": "NCT02616185", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "EVET", "sponsor": "Pfizer", "startDate": "2015-12-30", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR)", "url": "https://clinicaltrials.gov/study/NCT02616185" }, { "acronym": null, "application": "ECT", "completionDate": "2015-01", "conditions": "Colorectal Adenocarcinoma", "enrollment": "5", "interventions": "DRUG: Electrochemotherapy", "nct": "NCT02709811", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": "ECT", "resultsReported": "hayir", "sponsor": "IGEA", "startDate": "2012-08", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "INTERVENTIONAL", "summary": "Electrochemotherapy (ECT) is a non-thermal tumour ablation modality. It consists of the local potentiation, by means of local reversible electroporation of tumour tissues, of the antitumor activity of non-permeant or poorly permeant anticancer drugs already possessing intrinsic cytotoxicity. ECT has proved to be effective in the treatment of various cutaneous tumour nodules of any origin. Mostly ECT is offered to patients in case of multiple cutaneous metastases, when they cannot be excised, due to their number or localization. This study investigate the application of ECT in the treatment of liver metastases from colorectal adenocarcinoma, for which other thermal cytoreductive methods would be risky compared to the supposed expected clinical benefits.", "title": "Safety and Feasibility of Electrochemotherapy in Unresectable Colorectal Adenocarninoma Liver Metastases", "url": "https://clinicaltrials.gov/study/NCT02709811" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2017-04", "conditions": "Hepatocellular Cancer, Metastatic Liver Cancer", "enrollment": "10", "interventions": "", "nct": "NCT02787954", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "The University of Texas Health Science Center, Houston", "startDate": "2016-01", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Prospective Tumor Response Evaluation", "url": "https://clinicaltrials.gov/study/NCT02787954" }, { "acronym": null, "application": "IRE", "completionDate": "2020-09-23", "conditions": "Hepatic Malignant Tumors, Pancreatic Cancer", "enrollment": "11", "interventions": "", "nct": "NCT02822716", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Chinese University of Hong Kong", "startDate": "2013-07-22", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Irreversible Electroporation for Inoperable Hepatic and Pancreatic Malignancy", "url": "https://clinicaltrials.gov/study/NCT02822716" }, { "acronym": null, "application": "IRE", "completionDate": "2020-02-25", "conditions": "Pancreatic Cancer", "enrollment": "14", "interventions": "", "nct": "NCT02926040", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "Insel Gruppe AG, University Hospital Bern", "startDate": "2016-10", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Quality of Life After in Situ IRE in Locally Advanced Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT02926040" }, { "acronym": null, "application": "IRE", "completionDate": "2020-02-25", "conditions": "Pancreatic Cancer", "enrollment": "26", "interventions": "", "nct": "NCT02952859", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "Insel Gruppe AG, University Hospital Bern", "startDate": "2017-01", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Impact of Margin-accentuation IRE in Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT02952859" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2020-02-25", "conditions": "Pancreatic Cancer", "enrollment": "38", "interventions": "", "nct": "NCT03069599", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": null, "resultsReported": "hayir", "sponsor": "Insel Gruppe AG, University Hospital Bern", "startDate": "2017-02-15", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Immune Response After Pancreatic Cancer Treatment", "url": "https://clinicaltrials.gov/study/NCT03069599" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2022-08-13", "conditions": "Pancreatic Cancer, Pancreas Cancer, Cancer of the Pancreas", "enrollment": "15", "interventions": "", "nct": "NCT03122106", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "EVET", "sponsor": "Washington University School of Medicine", "startDate": "2018-01-05", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy", "url": "https://clinicaltrials.gov/study/NCT03122106" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2023-05-01", "conditions": "Triple Negative Breast Cancer, Triple Negative Breast Neoplasms, TNBC - Triple-Negative Breast Cancer", "enrollment": "18", "interventions": "", "nct": "NCT03199040", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": null, "resultsReported": "EVET", "sponsor": "Washington University School of Medicine", "startDate": "2019-07-23", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy", "url": "https://clinicaltrials.gov/study/NCT03199040" }, { "acronym": null, "application": "ECT", "completionDate": "2018-12-21", "conditions": "Pancreatic Cancer", "enrollment": "1", "interventions": "DEVICE: Electrochemotherapy with Bleomycin", "nct": "NCT03225781", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Universita di Verona", "startDate": "2017-07-01", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "INTERVENTIONAL", "summary": "Electrochemotherapy is a type of electroporation that allows the delivery of drugs to the cells through the local creation of pores in the cell membrane. The electric pulses can be applied directly to the neoplastic cells, allowing for the local concentration of a possible chemotherapeutic agent administered through the bloodstream. This technique does not use heat nor other thermal energies and it is performed using special needles/electrodes linked to a generator (\"porator\"). In this study this technique will be applied on unresectable pancreatic cancer, already submitted to neoadjuvant treatment and still unresectable, through laparotomy. Bleomycin will be the chemotherapeutic agent.", "title": "Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT03225781" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2022-09-20", "conditions": "Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive, Metastatic Malignant Neoplasm", "enrollment": "41", "interventions": "", "nct": "NCT03439085", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "EVET", "sponsor": "M.D. Anderson Cancer Center", "startDate": "2018-11-14", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers", "url": "https://clinicaltrials.gov/study/NCT03439085" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2023-08-19", "conditions": "Hepatocellular Carcinoma", "enrollment": "43", "interventions": "", "nct": "NCT03630640", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Assistance Publique - Hôpitaux de Paris", "startDate": "2018-10-11", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by Electroporation", "url": "https://clinicaltrials.gov/study/NCT03630640" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2022-07-31", "conditions": "Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Unresectable Head and Neck Squamous Cell Carcinoma", "enrollment": "14", "interventions": "", "nct": "NCT03823131", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "EVET", "sponsor": "Chase Heaton, MD", "startDate": "2019-05-02", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Optimizing Antitumor Immunity Using Plasmid Electroporation, Pembrolizumab, and Epacadostat", "url": "https://clinicaltrials.gov/study/NCT03823131" }, { "acronym": null, "application": "IRE", "completionDate": "2023-07-12", "conditions": "Metastatic Pancreatic Cancer", "enrollment": "8", "interventions": "", "nct": "NCT04212026", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "IRE", "resultsReported": "hayir", "sponsor": "University Hospital, Basel, Switzerland", "startDate": "2020-06-28", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Irreversible Electroporation (IRE) Followed by Nivolumab in Patients With Metastatic Pancreatic Cancer.", "url": "https://clinicaltrials.gov/study/NCT04212026" }, { "acronym": "PanECT", "application": "ECT", "completionDate": "2021-03-09", "conditions": "Pancreas Cancer", "enrollment": "3", "interventions": "PROCEDURE: Electrochemotherapy - electroporation with Cliniporator Vitae® and chemotherapy drug Bleomycin PHC 15 e. (United States Pharmacopeia - USP)", "nct": "NCT04281290", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "ECT", "resultsReported": "EVET", "sponsor": "University Medical Centre Ljubljana", "startDate": "2020-07-13", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "INTERVENTIONAL", "summary": "The aim of the study is to evaluate toxicity and effectiveness of electrochemotherapy (ECT) with bleomycin in pancreatic cancer in clinical study phase I and II. After surgical resection of pancreatic cancer, the posterior resection surface will be treated with ECT with the intention to lower disease recurrence rate. The study will include 20 patients in phase I clinical study and additional 20 patients in phase II clinical study (or in the extension of the clinical study), which will fulfill inclusion criteria. Treatment effectiveness will be evaluated by US or CT imaging, to detect early local recurrence of the disease. Long term effectiveness of the treatment will be evaluated by frequent and precise patient follow-up. During follow-up clinical examination, laboratory tests, tumor markers (Ca 19-9 and CEA) and US/CT imaging will be performed. The secondary objectives of the trial are ", "title": "Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study)", "url": "https://clinicaltrials.gov/study/NCT04281290" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2021-12-07", "conditions": "COVID-19|Protection Against COVID-19 and Infections With SARS-CoV- 2|COVID-19 Immunisation", "enrollment": "68", "interventions": "BIOLOGICAL: COVID-eVax|DEVICE: Cliniporator® and EPSGun", "nct": "NCT04788459", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": null, "sponsor": "Takis", "startDate": "2021-02-25", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "INTERVENTIONAL", "summary": "This is a multicentre, open-label Phase 1/2 study, with a first-in-human (FIH) dose escalation part (Phase 1 study) followed by an open-label single arm (or two-arms, randomized) dose expansion part (Phase 2 study). The vaccine will be administered by intramuscular (IM) injection followed by electroporation (EP) applied to the injection site. The study is aimed at assessing the safety and immunogenicity of COVID-eVax, a DNA plasmid-based vaccine whose target antigen is a portion of the S protein of SARS-CoV-2 virus (the Receptor Binding Domain located in the CTD1 of the S1 region of the S protein). In animal models COVID-eVax was safe and induced high immunological humoral and cellular response.", "title": "Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers", "url": "https://clinicaltrials.gov/study/NCT04788459" }, { "acronym": null, "application": "IRE", "completionDate": "2023-08-30", "conditions": "Pancreas Cancer", "enrollment": "9", "interventions": "", "nct": "NCT05435053", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Ismail Gögenur", "startDate": "2022-09-08", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Irreversible Electroporation + Nivolumab for Patients With Metastatic Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT05435053" }, { "acronym": null, "application": "Kardiyak PFA", "completionDate": "2025-11-16", "conditions": "Atrial Fibrillation Paroxysmal", "enrollment": "198", "interventions": "", "nct": "NCT06364215", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Jorge Romero", "startDate": "2024-10-08", "status": "TERMINATED", "statusKey": "terminated", "statusLabel": "Erken Sonlandırıldı", "studyType": "", "summary": null, "title": "Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation", "url": "https://clinicaltrials.gov/study/NCT06364215" }, { "acronym": null, "application": "ECT", "completionDate": null, "conditions": "Pancreatic Cancer", "enrollment": "0", "interventions": "", "nct": "NCT00027521", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Ichor Medical Systems Incorporated", "startDate": "2000-12", "status": "WITHDRAWN", "statusKey": "withdrawn", "statusLabel": "Geri Çekildi", "studyType": "", "summary": null, "title": "Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT00027521" }, { "acronym": null, "application": "ECT", "completionDate": "2014-02", "conditions": "Ulcerated Cutaneous Metastases", "enrollment": "98", "interventions": "DRUG: Electrochemotherapy|RADIATION: Radiotherapy|DRUG: Bleomycin", "nct": "NCT00918593", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Copenhagen University Hospital at Herlev", "startDate": "2009-12", "status": "WITHDRAWN", "statusKey": "withdrawn", "statusLabel": "Geri Çekildi", "studyType": "INTERVENTIONAL", "summary": "By applying short electric pulses to cells, the cell membranes can become permeabilised (electroporation). This can be used augment the effect of chemotherapy, by providing direct access to the cell cytosol. For the drug bleomycin, the enhancement of effect is several hundred fold, enabling once-only treatment. The investigators wish compare electrochemotherapy with radiotherapy when treating ulcerated cutaneous metastases up to 5 cm in diameter from any kind of histology.", "title": "Palliative Treatment of Ulcerated Cutaneous Metastases: Trial Between Electrochemotherapy and Radiotherapy", "url": "https://clinicaltrials.gov/study/NCT00918593" }, { "acronym": null, "application": "ECT", "completionDate": "2015-06", "conditions": "Breast Cancer|Skin Metastases", "enrollment": "0", "interventions": "DRUG: Electrochemotherapy", "nct": "NCT01479946", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Uppsala University Hospital", "startDate": "2011-10", "status": "WITHDRAWN", "statusKey": "withdrawn", "statusLabel": "Geri Çekildi", "studyType": "INTERVENTIONAL", "summary": "Electroporation combined with chemotherapy (ECT) has been shown to be an effective treatment for breast cancer that has spread to skin. In routine clinical practise, ECT is offered to patients when all other treatment options have been exhausted. This study tests the hypothesis that early treatment with ECT may result in improved local control of skin metastases, improved quality of life and reduced health care costs. Patients are randomised to either ECT given as early as possible in the course of the disease or delaying ECT for at least 6 months.", "title": "Electrochemotherapy For The Treatment Of Breast Cancer That Has Spread to the Skin", "url": "https://clinicaltrials.gov/study/NCT01479946" }, { "acronym": null, "application": "Gen Elektrotransferi", "completionDate": "2014-03", "conditions": "Melanoma", "enrollment": "0", "interventions": "", "nct": "NCT01764009", "phase": "PHASE1|PHASE2", "phaseLabel": "Faz 1/2", "regime": null, "resultsReported": "hayir", "sponsor": "Valerio Therapeutics", "startDate": "2012-06", "status": "WITHDRAWN", "statusKey": "withdrawn", "statusLabel": "Geri Çekildi", "studyType": "", "summary": null, "title": "Safety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic Melanoma", "url": "https://clinicaltrials.gov/study/NCT01764009" }, { "acronym": null, "application": "ECT", "completionDate": "2019-05-31", "conditions": "Glioblastoma", "enrollment": "0", "interventions": "DEVICE: TMS", "nct": "NCT02283944", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": "ECT", "resultsReported": "hayir", "sponsor": "University of Aarhus", "startDate": "2015-01", "status": "WITHDRAWN", "statusKey": "withdrawn", "statusLabel": "Geri Çekildi", "studyType": "INTERVENTIONAL", "summary": "The proposed project aims to develop novel electrochemotherapeutic treatment of glioblastoma multiforme (GBM). Standard treatment has limited effect on survival and quality of life. Electrochemotherapy is a novel and promising treatment, which has demonstrated convincing results in the treatment of various types of carcinoma. The treatment is based on a combination of electrical current stimulation of tumor cells and simultaneous administration of chemotherapeutic drugs. Electrochemotherapy works by inducing an electrical current between implanted electrodes in the tumor tissue, causing electroporation of the cancer cell membranes, and thereby increasing the cellular permeability and drug uptake. Electrochemotherapy has proven to be an efficient way of considerably increasing the potency of the chemotherapeutic drug bleomycin in malignant cells in skin tumors and carcinoma metastases, an", "title": "TMS Electrochemotherapy for Glioblastoma Multiforme", "url": "https://clinicaltrials.gov/study/NCT02283944" }, { "acronym": null, "application": "IRE", "completionDate": "2025-01-01", "conditions": "Prostatic Neoplasms", "enrollment": "0", "interventions": "", "nct": "NCT02430649", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Fuda Cancer Hospital, Guangzhou", "startDate": "2015-01-01", "status": "WITHDRAWN", "statusKey": "withdrawn", "statusLabel": "Geri Çekildi", "studyType": "", "summary": null, "title": "Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms", "url": "https://clinicaltrials.gov/study/NCT02430649" }, { "acronym": null, "application": "ECT", "completionDate": "2017-10", "conditions": "Pancreatic Adenocarcinoma", "enrollment": "0", "interventions": "DRUG: FOLFIRINOX|DEVICE: Electroporation", "nct": "NCT02592395", "phase": "PHASE1", "phaseLabel": "Faz 1", "regime": "ECT", "resultsReported": "hayir", "sponsor": "The University of Texas Health Science Center, Houston", "startDate": "2015-10", "status": "WITHDRAWN", "statusKey": "withdrawn", "statusLabel": "Geri Çekildi", "studyType": "INTERVENTIONAL", "summary": "The purpose of this study is to see how well electrochemotherapy works at treating people with Stage III pancreatic adenocarcinoma. Electrochemotherapy is a treatment that combines electroporation and chemotherapy administration. Electroporation uses an electric current to produce holes in pancreatic tumor, which causes the tumor cells to die or take up a higher concentration of administered chemotherapy agent. This study will test the safety and look at the effect of electrochemotherapy in the treatment of stage III pancreatic adenocarcinoma. This study will also help to find the safest and most effective amount of electroporation voltage to apply to this type of tumor.", "title": "Study of FOLFIRINOX Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma", "url": "https://clinicaltrials.gov/study/NCT02592395" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2018-09-30", "conditions": "Hepatocellular Carcinoma, Immune Response", "enrollment": "0", "interventions": "", "nct": "NCT03040453", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "Karolinska Institutet", "startDate": "2017-01-01", "status": "WITHDRAWN", "statusKey": "withdrawn", "statusLabel": "Geri Çekildi", "studyType": "", "summary": null, "title": "Immunological Response After Ablative Therapy in the Liver", "url": "https://clinicaltrials.gov/study/NCT03040453" }, { "acronym": null, "application": "IRE", "completionDate": "2025-01", "conditions": "Pancreatic Adenocarcinoma Resectable", "enrollment": "0", "interventions": "", "nct": "NCT03337997", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": null, "resultsReported": "hayir", "sponsor": "University of Saskatchewan", "startDate": "2021-10-01", "status": "WITHDRAWN", "statusKey": "withdrawn", "statusLabel": "Geri Çekildi", "studyType": "", "summary": null, "title": "A Pilot Study of IRE for Resectable Pancreatic Cancer", "url": "https://clinicaltrials.gov/study/NCT03337997" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2024-05-31", "conditions": "Renal Cell Carcinoma", "enrollment": "0", "interventions": "", "nct": "NCT03598816", "phase": "PHASE2", "phaseLabel": "Faz 2", "regime": null, "resultsReported": "hayir", "sponsor": "Washington University School of Medicine", "startDate": "2020-08-31", "status": "WITHDRAWN", "statusKey": "withdrawn", "statusLabel": "Geri Çekildi", "studyType": "", "summary": null, "title": "PolyImmune {Durvalumab (MEDI4736) and Tremelimumab} & Vaccine Orchestrated Treatment for Patients With Advanced/Metastatic Renal Cell Carcinoma", "url": "https://clinicaltrials.gov/study/NCT03598816" }, { "acronym": null, "application": "IRE", "completionDate": "2025-03-30", "conditions": "Liver Metastases, Hepatocellular Carcinoma, Bile Duct Cancer", "enrollment": "0", "interventions": "", "nct": "NCT04404647", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery", "startDate": "2020-06-01", "status": "WITHDRAWN", "statusKey": "withdrawn", "statusLabel": "Geri Çekildi", "studyType": "", "summary": null, "title": "Irreversible Electroporation of Unresectable Liver Tumors", "url": "https://clinicaltrials.gov/study/NCT04404647" }, { "acronym": null, "application": "IRE", "completionDate": "2022-06-01", "conditions": "Cholangiocarcinoma, Interventional Imaging", "enrollment": "0", "interventions": "", "nct": "NCT04717687", "phase": "NA", "phaseLabel": "Faz Dışı", "regime": "IRE", "resultsReported": "hayir", "sponsor": "Poitiers University Hospital", "startDate": "2021-05-01", "status": "WITHDRAWN", "statusKey": "withdrawn", "statusLabel": "Geri Çekildi", "studyType": "", "summary": null, "title": "Pilot Study on the Evaluation of Irreversible Electroporation Technique in Infiltrating Perihilar Cholangiocarcinoma", "url": "https://clinicaltrials.gov/study/NCT04717687" }, { "acronym": null, "application": "ECT", "completionDate": "2025-08-31", "conditions": "Desmoid Fibromatosis", "enrollment": "0", "interventions": "", "nct": "NCT06660121", "phase": "", "phaseLabel": "Belirtilmemiş", "regime": "ECT", "resultsReported": "hayir", "sponsor": "Istituto Ortopedico Rizzoli", "startDate": "2024-10-17", "status": "WITHDRAWN", "statusKey": "withdrawn", "statusLabel": "Geri Çekildi", "studyType": "", "summary": null, "title": "Electrochemotherapy for Desmoid Tumors", "url": "https://clinicaltrials.gov/study/NCT06660121" }, { "acronym": null, "application": "Belirsiz", "completionDate": "2030-08", "conditions": "Melanoma BRAF V600E/K Mutated", "enrollment": "0", "interventions": "", "nct": "NCT07092410", "phase": "PHASE4", "phaseLabel": "Faz 4", "regime": null, "resultsReported": "hayir", "sponsor": "SRH Wald-Klinikum Gera GmbH", "startDate": "2025-08", "status": "WITHDRAWN", "statusKey": "withdrawn", "statusLabel": "Geri Çekildi", "studyType": "", "summary": null, "title": "Surgical or Radiotherapeutic Intervention Concerning Large Singular Stable to Progressive Metastases in Patients With BRAFV600-mutated Melanoma Receiving Treatment With Encorafenib + Binimetinib", "url": "https://clinicaltrials.gov/study/NCT07092410" } ]